UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 419.

A

Agarwal, A; Kocjan, G; (2009) FNAC Thyroid Reporting Categories: Value of Using the British Thyroid Association (Thy 1 to Thy 5) Thyroid FNAC Reporting Guidelines. CYTOPATHOLOGY , 20 (2) 133 - 134. 10.1111/j.1365-2303.2008.00625.x.

Ahlskog, JKJ; Schliemann, C; Marlind, J; Qureshi, U; Ammar, A; Pedley, RB; Neri, D; (2009) Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours. BRIT J CANCER , 101 (4) 645 - 657. 10.1038/sj.bjc.6605200.

Ahmed, N; Salsman, VS; Yvon, E; Louis, CU; Perlaky, L; Wels, WS; ... Gottschalk, S; + view all (2009) Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression. MOL THER , 17 (10) 1779 - 1787. 10.1038/mt.2009.133.

Altvater, B; Landmeier, S; Pscherer, S; Temme, J; Schweer, K; Kailayangiri, S; ... Rossig, C; + view all (2009) 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells. CLIN CANCER RES , 15 (15) 4857 - 4866. 10.1158/1078-0432.CCR-08-2810.

Amit, I; Garber, M; Chevrier, N; Leite, AP; Donner, Y; Eisenhaure, T; ... Regev, A; + view all (2009) Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses. Science , 326 (5950) 257 - 263. 10.1126/science.1179050.

An, S; Henriquez, N; Puls, F; Brandner, S; (2009) Oligodendrogliomas: relation of morphology to 1p/19q genotype. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 11 - 12). BLACKWELL PUBLISHING

André, T; Boni, C; Navarro, M; Tabernero, J; Hickish, T; Topham, C; ... de Gramont, A; + view all (2009) Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol , 27 (19) 3109 - 3116. 10.1200/JCO.2008.20.6771.

Apostolidou, S; Hadwin, R; Burnell, M; Jones, A; Baff, D; Pyndiah, N; ... Widschwendter, M; + view all (2009) DNA methylation analysis in liquid-based cytology for cervical cancer screening. INT J CANCER , 125 (12) 2995 - 3002. 10.1002/ijc.24745.

Arkenau, H; Evans, J; Lokelma, M; Roxburgh, P; Morisson, R; Coffey, M; ... de Bono, J; + view all (2009) A phase I study of the combination of intravenous Reolysin (REO) and gemcitabine (GEM) in patients (pts) with advanced cancer. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Arkenau, H-T; (2009) Capecitabine/oxaliplatin results in outcome similar to infusional 5 FU/leucovorin/oxaliplatin in MCRC: Results of a meta-analysis. American Journal of Hematology/ Oncology , 8 (5)

Arkenau, HT; (2009) Gastric cancer in the era of molecularly targeted agents: current drug development strategies. J Cancer Res Clin Oncol , 135 (7) 855 - 866. 10.1007/s00432-009-0583-7.

Arkenau, HT; Barriuso, J; Olmos, D; Ang, JE; de Bono, J; Judson, I; Kaye, S; (2009) Prospective validation of a prognostic score to improve patient selection for oncology phase I trials. J Clin Oncol , 27 (16) 2692 - 2696. 10.1200/JCO.2008.19.5081.

Arkenau, HT; Brunetto, AT; Barriuso, J; Olmos, D; Eaton, D; de Bono, J; ... Kaye, S; + view all (2009) Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancer. Oncology , 76 (3) 151 - 156. 10.1159/000195884.

Averdam, A; Petersen, B; Beck, S; Reinhardt, R; Walter, L; (2009) A novel system of polymorphic NK cell receptors identified in primates. In: TISSUE ANTIGENS. (pp. 386 - 386). WILEY-BLACKWELL PUBLISHING, INC

Averdam, A; Petersen, B; Rosner, C; Neff, J; Roos, C; Eberle, M; ... Walter, L; + view all (2009) A Novel System of Polymorphic and Diverse NK Cell Receptors in Primates. PLOS GENET , 5 (10) , Article e1000688. 10.1371/journal.pgen.1000688. Green open access
file

B

Backdahl, L; Bushell, A; Beck, S; (2009) Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation. INT J BIOCHEM CELL B , 41 (1) 176 - 184. 10.1016/j.biocel.2008.08.023.

Backdahl, L; Herberth, M; Wilson, G; Tate, P; Campos, LS; Cortese, R; ... Beck, S; + view all (2009) Gene body methylation of the dimethylarginine dimethylamino-hydrolase 2 (Ddah2) gene is an epigenetic biomarker for neural stem cell differentiation. EPIGENETICS , 4 (4) 248 - 254.

Banerjee, L; Mansour, M; Khwaja, A; (2009) Combined blockade of PI3-kinase and mTOR synergizes with gamma-secretase inhibitors to induce a high level of cell death in T-cell acute lymphoblastic leukaemia cells with activated Notch signalling. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 9 - 10). WILEY-BLACKWELL PUBLISHING, INC

Baou, M; Jewell, A; Muthurania, A; Wickremasinghe, RG; Yong, KL; Carr, R; ... Murphy, JJ; + view all (2009) Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells. LEUKEMIA , 23 (5) 986 - 989. 10.1038/leu.2008.340.

Bartlett, JMS; Campbell, FM; Ibrahim, M; Thomas, J; Wenyck, I; Ellis, IO; ... Miller, K; + view all (2009) A UK NEQAS ring study evaluating observer variation in the diagnosis of HER2 amplification using the Kreatech (TM) HER2 FISH probe. In: CANCER RESEARCH. (pp. 206S - 206S). AMER ASSOC CANCER RESEARCH

Bartlett, JMS; Campbell, FM; Ibrahim, M; Wencyk, P; Ellis, I; Kay, E; ... Miller, K; + view all (2009) Chromogenic In Situ Hybridization A Multicenter Study Comparing Silver In Situ Hybridization With FISH. AM J CLIN PATHOL , 132 (4) 514 - 520. 10.1309/AJCPXY3MJ6GSRCYP.

Bartlett, JMS; Miller, K; (2009) HER2: Closing the Gap Between Laboratory Testing and Clinical Practice Reply. AM J CLIN PATHOL , 131 (6) 898 - 899.

Baxter-Lowe, LA; Maiers, M; Spellman, SR; Haagenson, MD; Wang, T; Fernandez-Vina, M; ... Hurley, CK; + view all (2009) HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. 971 - 981.

Beck, S; (2009) Reverse Phenotyping: Towards an integrated (epi)genomic approach to complex phenotypes and common disease. In: JOURNAL OF MEDICAL GENETICS. (pp. S31 - S31). B M J PUBLISHING GROUP

Behjati, S; Bamfo, JEAK; Bates, AW; Veerareddy, S; (2009) A near miss: Lessons from a case of omental pregnancy. J OBSTET GYNAECOL , 29 (6) 559 - 560. 10.1080/01443610902984946.

Behjati, S; Zilbauer, M; Heuschkel, R; Phillips, A; Salvestrini, C; Torrente, F; Bates, AW; (2009) Defining Eosinophilic Colitis in Children: Insights From a Retrospective Case Series. J PEDIATR GASTR NUTR , 49 (2) 208 - 215.

Bell, CG; Beck, S; (2009) Advances in the identification and analysis of allele-specific expression. Genome Med , 1 (5) 56 - ?. 10.1186/gm56.

Bell, CG; Wood, DR; Cheong, SJ; Kwan, E; Sinosich, M; Delprado, W; Baumgart, KW; (2009) Molecular confirmation of pathological specimen integrity in Australasia. Pathology , 41 (3) 280 - 283. 10.1080/00313020902756311.

Bellodi, C; Lidonnici, MR; Hamilton, A; Helgason, GV; Soliera, AR; Ronchetti, M; ... Calabretta, B; + view all (2009) Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J CLIN INVEST , 119 (5) 1109 - 1123. 10.1172/JCI35660.

Bendall, SC; Hughes, C; Campbell, JL; Stewart, MH; Pittock, P; Liu, S; ... Lajoie, GA; + view all (2009) An enhanced mass spectrometry approach reveals human embryonic stem cell growth factors in culture. Mol Cell Proteomics , 8 (3) 421 - 432. 10.1074/mcp.M800190-MCP200.

Berenjeno, IM; Vanhaesebroeck, B; (2009) PI3K regulatory subunits lose control in cancer. Cancer Cell , 16 (6) 449 - 450. 10.1016/j.ccr.2009.11.017.

Bergamini, G; Cigana, C; Sorio, C; Della Peruta, M; Pompella, A; Corti, A; ... Melotti, P; + view all (2009) Effects of Azithromycin on Glutathione S-Transferases in Cystic Fibrosis Airway Cells. AM J RESP CELL MOL , 41 (2) 199 - 206. 10.1165/rcmb.2008-0013OC.

Berro, M; Mayor, NP; Cooke, L; Kusminsky, G; Marsh, SGE; Madrigal, JA; Shaw, BE; (2009) TGFB1 codon 10 polymorphism: Impact on outcome in allogeneic unrelated donor hematopoietic stem cell transplantation. In: TISSUE ANTIGENS. (pp. 488 - 488). WILEY-BLACKWELL PUBLISHING, INC

Beyan, H; Buckley, LR; Bustin, SA; Yousaf, N; Pozzilli, P; Leslie, RD; (2009) Altered monocyte cyclo-oxygenase response in non-obese diabetic mice. Clin Exp Immunol , 155 (2) 304 - 310. 10.1111/j.1365-2249.2008.03825.x.

Bhosle, J; Makris, A; Hartley, JA; Hochhauser, D; (2009) Effect of chronic exposure to tyrosine kinase inhibitors on chemotherapy-induced DNA damage in the SKBR3 breast cancer cell line. In: CANCER RESEARCH. (pp. 117S - 117S). AMER ASSOC CANCER RESEARCH

Billottet, C; Banerjee, L; Vanhaesebroeck, B; Khwaja, A; (2009) Inhibition of Class I Phosphoinositide 3-Kinase Activity Impairs Proliferation and Triggers Apoptosis in Acute Promyelocytic Leukemia without Affecting Atra-Induced Differentiation. CANCER RES , 69 (3) 1027 - 1036. 10.1158/0008-5472.CAN-08-2608.

Black, E; Glasspool, DW; Grando, MA; Patkar, V; Fox, J; (2009) Goal-Based Decisions for Dynamic Planning. In: Combi, C and Shahar, Y and AbuHanna, A, (eds.) ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS. (pp. 96 - 100). SPRINGER-VERLAG BERLIN

Boone, JJM; Bhosle, J; Tilby, MJ; Hartley, JA; Hochhauser, D; (2009) Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents. MOL CANCER THER , 8 (11) 3015 - 3023. 10.1158/1535-7163.MCT-09-0219.

Bowen, D; Groves, MJ; Burnett, AK; Patel, Y; Allen, C; Green, C; ... Med Res Council Adult Leukaemia Wo,; + view all (2009) TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. LEUKEMIA , 23 (1) 203 - 206. 10.1038/leu.2008.173.

Bowers, SR; Mirabella, F; Calero-Nieto, FJ; Valeaux, S; Hadjur, S; Baxter, EW; ... Cockerill, PN; + view all (2009) A Conserved Insulator That Recruits CTCF and Cohesin Exists between the Closely Related but Divergently Regulated Interleukin-3 and Granulocyte-Macrophage Colony-Stimulating Factor Genes. MOL CELL BIOL , 29 (7) 1682 - 1693. 10.1128/MCB.01411-08.

Brewin, J; Mancao, C; Straathof, K; Karlsson, H; Samarasinghe, S; Amrolia, PJ; Pule, M; (2009) Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. BLOOD , 114 (23) 4792 - 4803. 10.1182/blood-2009-07-228387.

Brown, AC; Hallouane, D; Mawby, WJ; Karet, FE; Saleem, MA; Howie, AJ; Toye, AM; (2009) RhCG is the major putative ammonia transporter expressed in the human kidney, and RhBG is not expressed at detectable levels. Am J Physiol Renal Physiol , 296 (6) F1279 - F1290. 10.1152/ajprenal.00013.2009.

Brown, NW; Hiwarkar, P; Shaw, BE; Kulkarni, S; Saso, R; Evans, S; ... Tredger, JM; + view all (2009) Mycophenolic Acid Concentration Monitoring for Mycophenolate Mofetil-treated Graft versus Host Disease. In: THERAPEUTIC DRUG MONITORING. (pp. 663 - 663). LIPPINCOTT WILLIAMS & WILKINS

Bruce, AW; Lopez-Contreras, AJ; Flicek, P; Down, TA; Dhami, P; Dillon, SC; ... Vetrie, D; + view all (2009) Functional diversity for REST (NRSF) is defined by in vivo binding affinity hierarchies at the DNA sequence level. GENOME RES , 19 (6) 994 - 1005. 10.1101/gr.089086.108.

Brunelli, M; Manfrin, E; Martignoni, G; Miller, K; Remo, A; Reghellin, D; ... Bonetti, F; + view all (2009) Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification. AM J CLIN PATHOL , 131 (5) 678 - 682. 10.1309/AJCP09VUTZWZXBMJ.

Bruno, L; Mazzarella, L; Hoogenkamp, M; Hertweck, A; Cobb, BS; Sauer, S; ... Merkenschlager, M; + view all (2009) Runx proteins regulate Foxp3 expression. J EXP MED , 206 (11) 2329 - 2337. 10.1084/jem.20090226.

C

Camp, PG; Coxson, HO; Levy, RD; Pillai, SG; Anderson, W; Vestbo, J; ... Paré, PD; + view all (2009) Sex differences in emphysema and airway disease in smokers. Chest , 136 (6) 1480 - 1488. 10.1378/chest.09-0676.

Cantu, C; Ierardi, R; Fugazza, C; Grande, V; Alborelli, I; Ottolenghi, S; ... Ronchi, A; + view all (2009) SOX6 OVEREXPRESSION IN HUMAN ERYTHROID PROGENITORS STRONGLY ENHANCES THEIR TERMINAL MATURATION. In: EXPERIMENTAL HEMATOLOGY. (pp. S12 - S12). ELSEVIER SCIENCE INC

Cappellini, MD; Perrotta, S; Agaoglu, L; Aydinok, Y; Capra, M; Canatan, D; ... Kattamis, A; + view all (2009) Efficacy and Safety of Deferasirox (Exjade (R)) in Patients with beta-Thalassemia Major Treated for up to 5 Years. In: BLOOD. (pp. 1558 - 1559). AMER SOC HEMATOLOGY

Carle, D; Bielack, S; Sydes, M; Butterfass-Bahloul, T; Calaminus, G; Jovic, G; ... Bernstein, M; + view all (2009) The European and American Osteosarcoma Study Group protocol EURAMOS 1: Successful transatlantic cooperation in osteosarcoma. In: Connective Tissue Oncology Society, Miami,.

Carpenter, JP; Alpendurada, F; Deac, M; Kirk, P; Porter, JB; Walker, JM; ... Pennell, DJ; + view all (2009) Impact of Myocardial Iron Loading On Right Ventricular Function. In: BLOOD. (pp. 794 - 794). AMER SOC HEMATOLOGY

Cave, J; Edwards, SG; Miller, RF; Ardeshna, KM; Lee, SM; (2009) Should we implement 'opt-out' HIV testing for patients with lymphoma? CLIN MED , 9 (4) 320 - 322.

Chanalaris, A; Grace, C; Gale, R; Linch, D; Nacheva, EP; (2009) GENOME PROFILING OF NORMAL KARYOTYPE AML WITH HIGH DENSITY ARRAY COMPARATIVE GENOME HYBRIDISATION. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 114 - 114). FERRATA STORTI FOUNDATION Gold open access

Chapgier, A; Kong, XF; Boisson-Dupuis, S; Jouanguy, E; Averbuch, D; Feinberg, J; ... Casanova, JL; + view all (2009) A partial form of recessive STAT1 deficiency in humans. J Clin Invest , 119 (6) 1502 - 1514. 10.1172/JCI37083.

Chapman, CE; Stainsby, D; Jones, H; Love, E; Massey, E; Win, N; ... Serious Hazards of Transfusion Steering Group,; + view all (2009) Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion , 49 (3) 440 - 452. 10.1111/j.1537-2995.2008.01948.x.

Cheng, YY; Siddle, HV; Beck, S; Eldridge, MDB; Belov, K; (2009) High levels of genetic variation at MHC class II DBB loci in the tammar wallaby (Macropus eugenii). IMMUNOGENETICS , 61 (2) 111 - 118. 10.1007/s00251-008-0347-6.

Cheng, YY; Wakefield, M; Siddle, HV; Coggill, PC; Herbert, CA; Beck, S; ... Eldridge, MDB; + view all (2009) Isolation and characterization of 10 MHC Class I-associated microsatellite loci in tammar wallaby (Macropus eugenii). MOL ECOL RESOUR , 9 (1) 346 - 349. 10.1111/j.1755-0998.2008.02401.x.

Cheung, CW; Khwaja, A; (2009) Stromal cell-mediated drug resistance in acute myeloid leukaemia (AML) is attenuated by PI103, a dual inhibitor of Class I PI3-Kinase (PI3K) and mTOR. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 2 - 2). WILEY-BLACKWELL PUBLISHING, INC

Chew, SK; Chen, P; Link, N; Galindo, KA; Pogue, K; Abrams, JM; (2009) Genome-wide silencing in Drosophila captures conserved apoptotic effectors. Nature , 460 (7251) 123 - 127. 10.1038/nature08087.

Chickarmane, V; Enver, T; Peterson, C; (2009) Computational Modeling of the Hematopoietic Erythroid-Myeloid Switch Reveals Insights into Cooperativity, Priming, and Irreversibility. PLOS COMPUT BIOL , 5 (1) , Article e1000268. 10.1371/journal.pcbi.1000268. Green open access
file

Chiou, A; Hägglöf, P; Orte, A; Chen, AY; Dunne, PD; Belorgey, D; ... Klenerman, D; + view all (2009) Probing neuroserpin polymerization and interaction with amyloid-beta peptides using single molecule fluorescence. Biophys J , 97 (8) 2306 - 2315. 10.1016/j.bpj.2009.07.057.

Collins, GP; Paterson, JC; Campbell, L; Mason, DY; Enver, T; Marafioti, T; (2009) EXPRESSION AND EPIGENETIC ANALYSIS OF KEY B-LINEAGE TRANSCRIPTIONAL PROGRAMMES IN HODGKIN/REED-STERNBERG CELLS. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 36 - 36). FERRATA STORTI FOUNDATION Gold open access

Constantinou, A; Epenetos, AA; Hreczuk-Hirst, D; Jain, S; Wright, M; Chester, KA; Deonarain, MP; (2009) Site-Specific Polysialylation of an Antitumor Single-Chain Fv Fragment. BIOCONJUGATE CHEM , 20 (5) 924 - 931. 10.1021/bc8005122.

Cooley, S; Trachtenberg, E; Bergemann, TL; Saeteurn, K; Klein, J; Le, CT; ... Weisdorf, DJ; + view all (2009) Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. 726 - 732.

Croucher, C; Whelan, JS; Møller, H; Davies, EA; (2009) Trends in the incidence and survival of cancer in teenagers and young adults: Regional analysis for South East England 1960 - 2002. Clinical Oncology , 21 417 - 424.

Cunningham, D; Sirohi, B; Pluzanska, A; Utracka-Hutka, B; Zaluski, J; Glynne-Jones, R; ... Cassidy, J; + view all (2009) Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer. Ann Oncol , 20 (2) 244 - 250. 10.1093/annonc/mdn638.

D

Dancey, G; Begent, RH; Meyer, T; (2009) Imaging in targeted delivery of therapy to cancer. TARGET ONCOL , 4 (3) 201 - 217. 10.1007/s11523-009-0119-8.

Dancey, G; Violet, J; Malaroda, A; Green, AJ; Sharma, SK; Francis, R; ... McNamara, C; + view all (2009) A Phase I Clinical Trial of CHT-25 a I-131-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma. CLIN CANCER RES , 15 (24) 7701 - 7710. 10.1158/1078-0432.CCR-09-1421.

Davies, MJ; Miranda, E; Roussel, BD; Kaufman, RJ; Marciniak, SJ; Lomas, DA; (2009) Neuroserpin polymers activate NF-kappaB by a calcium signaling pathway that is independent of the unfolded protein response. J Biol Chem , 284 (27) 18202 - 18209. 10.1074/jbc.M109.010744.

Davis, R; Sielaff, A; Ruprich, J; Westrate, L; Tronrud, C; Ferguson, A; ... Lee, M; + view all (2009) Design, synthesis, biophysical and biological studies of fluorescent Hoechst-polyamide hybrid molecules. ABSTR PAP AM CHEM S , 237 ? - ?.

de Fabiani, E; Gilardi, F; Galmozzi, A; Boraso, M; Bartesaghi, S; Torri, A; ... Marinovich, M; + view all (2009) EXPRESSION OF STEROL 27-HYDROXYLASE IN GLIAL CELLS AND ITS REGULATION BY LIVER X RECEPTOR SIGNALING. In: GLIA. (pp. S51 - S51). WILEY-LISS

Dearling, JLJ; Flynn, AA; Qureshi, U; Whiting, S; Boxer, GM; Green, A; ... Pedley, RB; + view all (2009) Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptake. NUCL MED BIOL , 36 (8) 883 - 894. 10.1016/j.nucmedbio.2009.07.003.

DeMeo, DL; Mariani, T; Bhattacharya, S; Srisuma, S; Lange, C; Litonjua, A; ... Silverman, EK; + view all (2009) Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene. Am J Hum Genet , 85 (4) 493 - 502. 10.1016/j.ajhg.2009.09.004.

Denard, J; Rundwasser, S; Laroudie, N; Gonnet, F; Naldini, L; Radrizzani, M; ... Svinartchouk, F; + view all (2009) Quantitative proteomic analysis of lentiviral vectors using 2-DE. Proteomics , 9 (14) 3666 - 3676. 10.1002/pmic.200800747.

Dennis, MY; Paracchini, S; Scerri, TS; Prokunina-Olsson, L; Knight, JC; Wade-Martins, R; ... Monaco, AP; + view all (2009) A Common Variant Associated with Dyslexia Reduces Expression of the KIAA0319 Gene. PLOS GENET , 5 (3) , Article e1000436. 10.1371/journal.pgen.1000436. Green open access
file

Desai, K; Bhattacharya, S; Srirajaskanthan, R; Morgan-Rowe, L; Toumpanakis, C; Meyer, T; Caplin, M; (2009) Analysis of association between carcinoid heart disease and mesenteric fibrosis in patients with midgut carcinoid tumour. In: JOURNAL OF CLINICAL ONCOLOGY.

Dignan, FL; Anthias, C; Ethell, ME; Morilla, R; Morilla, A; Davies, FE; ... Shaw, BE; + view all (2009) The Presence of Minimal Residual Disease Pre- and Post-Transplant Is Predictive of Outcome in Recipients of Allogeneic Transplantation for Acute Myeloid Leukaemia. In: BLOOD. (pp. 1020 - 1021). AMER SOC HEMATOLOGY

Dignan, FL; Evans, SO; Ethell, ME; Shaw, BE; Davies, FE; Dearden, CE; ... Potter, MN; + view all (2009) An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. BONE MARROW TRANSPL , 44 (1) 51 - 56. 10.1038/bmt.2008.427.

Ding, XY; Patel, M; Shen, DF; Herzlich, AA; Cao, XG; Villasmil, R; ... Chan, CC; + view all (2009) Enhanced HtrA2/Omi Expression in Oxidative Injury to Retinal Pigment Epithelial Cells and Murine Models of Neurodegeneration. INVEST OPHTH VIS SCI , 50 (10) 4957 - 4966. 10.1167/iovs.09-3381.

Dovey, CL; Aslanian, A; Sofueva, S; Yates, JR; Russell, P; (2009) Mms1-Mms22 complex protects genome integrity in Schizosaccharomyces pombe. DNA REPAIR , 8 (12) 1390 - 1399. 10.1016/j.dnarep.2009.09.008.

Durand, CA; Hartvigsen, K; Fogelstrand, L; Kim, S; Iritani, S; Vanhaesebroeck, B; ... Gold, MR; + view all (2009) Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses. J Immunol , 183 (9) 5673 - 5684. 10.4049/jimmunol.0900432.

E

Edinger, M; Powrie, F; Chakraverty, R; (2009) Regulatory Mechanisms in Graft-versus-Host Responses. Biology of Blood and Marrow Transplantation , 15 (1 SUPPL.) 2 - 6. 10.1016/j.bbmt.2008.10.013.

Ekeowa, UI; Gooptu, B; Belorgey, D; Hägglöf, P; Karlsson-Li, S; Miranda, E; ... Lomas, DA; + view all (2009) alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies. Clin Sci (Lond) , 116 (12) 837 - 850. 10.1042/CS20080484.

Enver, T; Jacobsen, SEW; (2009) DEVELOPMENTAL BIOLOGY Instructions writ in blood. NATURE , 461 (7261) 183 - 184. 10.1038/461183a.

Enver, T; Pera, M; Peterson, C; Andrews, PW; (2009) Stem Cell States, Fates, and the Rules of Attraction. CELL STEM CELL , 4 (5) 387 - 397. 10.1016/j.stem.2009.04.011.

Essafi, A; Gomes, AR; Pomeranz, KM; Zwolinska, AK; Varshochi, R; McGovern, UB; Lam, EW; (2009) Studying the subcellular localization and DNA-binding activity of FoxO transcription factors, downstream effectors of PI3K/Akt. Methods Mol Biol , 462 201 - 211. 10.1007/978-1-60327-115-8_13.

F

Fallah-Arani, F; Sivakumaran, J; Flutter, BR; Bennett, C; Chakraverty, R; (2009) Host CD11c(+) Dendritic Cells Are Required for Priming the Lympho-Haematopoietic Graft-Versus-Host Response but Not Graft-Versus-Host Disease. In: BLOOD. (pp. 966 - 967). AMER SOC HEMATOLOGY

Fazel, MZ; Gogalniceanu, P; Patel, A; Capitano, A; Kocjan, G; Falzon, M; Douek, M; (2009) Intra-operative touch imprint cytology for assessing sentinel lymph nodes in patients with lobular breast cancer. In: CANCER RESEARCH. (pp. 108S - 108S). AMER ASSOC CANCER RESEARCH

Fern, L; Ashton, J; Broonan, K; Irving, C; Millington, H; Starkey, C; ... Whelan, J; + view all (2009) Involving young people with cancer in research. The National Cancer Research Institute’s Teeange and Young Adult Core Consumer Group – a new and evolving model. In: National Cancer Research Institute Cancer Conference, 2009, Birmingham.

Fielding, AK; Rowe, JM; Richards, SM; Buck, G; Moorman, AV; Durrant, IJ; ... Goldstone, AH; + view all (2009) Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. BLOOD , 113 (19) 4489 - 4496. 10.1182/blood-2009-01-199380.

Finerty, MJ; Bingham, JP; Hartley, JA; Shipman, M; (2009) Azinomycin bisepoxides containing rigid aromatic linkers: synthesis, cytotoxicity and DNA interstrand cross-linking activity. TETRAHEDRON LETT , 50 (26) 3648 - 3650. 10.1016/j.tetlet.2009.03.123.

Fiore, MM; Mackie, IJ; (2009) Dual effect of Platelet Factor 4 on the activities of Factor Xa. BIOCHEM BIOPH RES CO , 379 (4) 1072 - 1075. 10.1016/j.bbrc.2009.01.016.

Fiore, MM; Mackie, IM; (2009) Mechanism of low-molecular-weight heparin reversal by platelet factor 4. Thromb Res , 124 (1) 149 - 155. 10.1016/j.thromres.2008.12.047.

FOLEY, JH; NESHEIM, ME; (2009) Soluble thrombomodulin partially corrects the premature lysis defect in FVIII-deficient plasma by stimulating the activation of thrombin activatable fibrinolysis inhibitor. Journal of Thrombosis and Haemostasis , 7 (3) 453 - 459. 10.1111/j.1538-7836.2008.03261.x.

Fong, LY; Wan, SG; Taccioli, C; Jiang, YB; Liu, XP; Croce, CM; Farber, JL; (2009) Zinc Deficiency Induces Upregulation of S100A8/A9 and Abolishes the Anticancer Effects of COX-2 Disruption in Murine Oral-Esophageal Cancer Prevention. J NUTRIGENET NUTRIGE , 2 (4-5) 211 - 211.

Ford, AM; Palmi, C; Bueno, C; Hong, D; Cardus, P; Knight, D; ... Greaves, M; + view all (2009) The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells. J CLIN INVEST , 119 (4) 826 - 836. 10.1172/JCI36428.

Forshew, T; Tatevossian, RG; Lawson, AR; Ma, J; Neale, G; Ogunkolade, BW; ... Sheer, D; + view all (2009) Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol , 218 (2) 172 - 181. 10.1002/path.2558.

Fox, J; Patkar, V; Chronakis, I; Begent, R; (2009) From practice guidelines to clinical decision support: closing the loop. J ROY SOC MED , 102 (11) 464 - 473. 10.1258/jrsm.2009.090010.

Francis, RE; Myatt, SS; Krol, J; Hartman, J; Peck, B; McGovern, UB; ... Lam, EW; + view all (2009) FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer. Int J Oncol , 35 (1) 57 - 68.

G

Gancheva, K; Postadjian, A; Brazma, D; Grace, C; Chanalaris, A; Nacheva, E; Apostolova, MD; (2009) COPY NUMBER VARIANTS: DISTRIBUTION IN PATIENTS WITH CORONARY ATHEROSCLEROSIS. BIOTECHNOL BIOTEC EQ , 23 (1) 1095 - 1100.

Gandhi, S; Wood-Kaczmar, A; Yao, Z; Plun-Favreau, H; Deas, E; Klupsch, K; ... Abramov, AY; + view all (2009) PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-induced Cell Death. MOL CELL , 33 (5) 627 - 638. 10.1016/j.molcel.2009.02.013. Gold open access

Garbowski, MW; Carpenter, JP; Smith, G; Pennell, DJ; Porter, JB; (2009) Calibration of Improved T2*Method for the Estimation of Liver Iron Concentration in Transfusional Iron Overload. In: BLOOD. (pp. 791 - 791). AMER SOC HEMATOLOGY

Garbowski, MW; Fabre, M; Evans, P; Porter, JB; (2009) Vitamin C Status in Transfusionally Iron-Overloaded Patients On Long-Term Deferasirox and Its Relationship to Myocardial Iron Removal. In: BLOOD. (pp. 792 - 792). AMER SOC HEMATOLOGY

Gardiner, C; Longair, I; Pescott, MA; Erwin, H; Hills, J; Machin, SJ; Cohen, H; (2009) Self-monitoring of oral anticoagulation: does it work outside trial conditions? J CLIN PATHOL , 62 (2) 168 - 171. 10.1136/jcp.2008.059634.

Gardiner, C; Machin, S; Mackie, I; (2009) Point-of-Care Testing in Hemostasis. Quality in Laboratory Hemostasis and Thrombosis 72 - 80. 10.1002/9781444303575.ch8.

Garofalo, M; Di Leva, G; Romano, G; Nuovo, G; Suh, SS; Ngankeu, A; ... Croce, CM; + view all (2009) miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation. CANCER CELL , 16 (6) 498 - 509. 10.1016/j.ccr.2009.10.014.

Gennarino, VA; Sardiello, M; Avellino, R; Meola, N; Maselli, V; Anand, S; ... Banfi, S; + view all (2009) MicroRNA target prediction by expression analysis of host genes. 481 - 490.

George, S; Lal, R; Camidge, DR; Arkenau, H; Chick, J; Poondru, S; ... Scurr, M; + view all (2009) Final results of a dose escalation (DE), pharmacokinetic (PK), and pharmacodynamic (PD) study of two schedules of OSI-930 in patients (pts) with advanced solid tumors. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Gerrard, G; Butters, TD; Ganeshaguru, K; Mehta, AB; (2009) Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. Eur J Pharmacol , 609 (1-3) 34 - 39. 10.1016/j.ejphar.2009.03.018.

Ghosh, AK; Shanafelt, TD; Cimmino, A; Taccioli, C; Volinia, S; Liu, CG; ... Kay, NE; + view all (2009) Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. BLOOD , 113 (22) 5568 - 5574. 10.1182/blood-2008-10-185686.

Gibson, F; Aldiss, S; Taylor, RM; Maguire, R; Kearney, N; (2009) Involving health professionals in the development of an advanced symptom management system for young people: The ASyMS (c)-YG study. EUR J ONCOL NURS , 13 (3) 187 - 192. 10.1016/j.ejon.2009.03.004.

Gibson, F; Pearce, S; Eden, T; Glaser, A; Hooker, L; Whelan, J; Kelly, D; (2009) CANCER IN YOUNG PEOPLE: A NARRATIVE STUDY TO EXPLORE THEIR EXPERIENCE FROM FIRST SYMPTOMS TO THE DIAGNOSIS OF CANCER. In: PEDIATR BLOOD CANCER. (pp. 751 - 751). WILEY-LISS

Gilardi, F; Viviani, B; Galmozzi, A; Boraso, M; Bartesaghi, S; Torri, A; ... de Fabiani, E; + view all (2009) EXPRESSION OF STEROL 27-HYDROXYLASE IN GLIAL CELLS AND ITS REGULATION BY LIVER X RECEPTOR SIGNALING. NEUROSCIENCE , 164 (2) 530 - 540. 10.1016/j.neuroscience.2009.08.003.

Gollmer, K; Asperti-Boursin, F; Tanaka, Y; Okkenhaug, K; Vanhaesebroeck, B; Peterson, JR; ... Stein, JV; + view all (2009) CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway. Blood , 114 (3) 580 - 588. 10.1182/blood-2009-01-200923.

Gooptu, B; Ekeowa, UI; Lomas, DA; (2009) Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights. Eur Respir J , 34 (2) 475 - 488. 10.1183/09031936.00096508.

Gooptu, B; Lomas, DA; (2009) Conformational pathology of the serpins: themes, variations, and therapeutic strategies. Annu Rev Biochem , 78 147 - 176. 10.1146/annurev.biochem.78.082107.133320.

Gooptu, B; Miranda, E; Nobeli, I; Mallya, M; Purkiss, A; Brown, SC; ... Barrett, TE; + view all (2009) Crystallographic and cellular characterisation of two mechanisms stabilising the native fold of alpha1-antitrypsin: implications for disease and drug design. J Mol Biol , 387 (4) 857 - 868. 10.1016/j.jmb.2009.01.069.

Gordon, WR; Roy, M; Vardar-Ulu, D; Garfinkel, M; Mansour, MR; Aster, JC; Blacklow, SC; (2009) Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. Blood , 113 (18) 4381 - 4390. 10.1182/blood-2008-08-174748.

Graf, T; Enver, T; (2009) Forcing cells to change lineages. NATURE , 462 (7273) 587 - 594. 10.1038/nature08533.

Green, CL; Koo, KK; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2009) PROGNOSTIC SIGNIFICANCE OF CEBPA MUTATIONS IN A LARGE COHORT OF YOUNGER ADULT PATIENTS WITH AML: IMPACT OF DOUBLE CEBPA MUTATIONS AND THE INTERACTION WITH FLT3 AND NPM1 MUTATIONS. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 431 - 431). FERRATA STORTI FOUNDATION Gold open access

Grimwade, D; Jovanovic, JV; Hills, RK; Nugent, EA; Patel, Y; Flora, R; ... Burnett, AK; + view all (2009) Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy. J CLIN ONCOL , 27 (22) 3650 - 3658. 10.1200/JCO.2008.20.1533.

Grun, B; Benjamin, E; Sinclair, J; Timms, JF; Jacobs, IJ; Gayther, SA; Dafou, D; (2009) Three-dimensional in vitro cell biology models of ovarian and endometrial cancer. CELL PROLIFERAT , 42 (2) 219 - 228. 10.1111/j.1365-2184.2008.00579.x.

Gunaratnam, M; Green, C; Moreira, JB; Moorhouse, AD; Kelland, LR; Moses, JE; Neidle, S; (2009) G-quadruplex compounds and cis-platin act synergistically to inhibit cancer cell growth in vitro and in vivo. Biochem Pharmacol , 78 (2) 115 - 122.

Gunaratnam, M; Swank, S; Haider, SM; Galesa, K; Reszka, AP; Beltran, M; ... Neidle, S; + view all (2009) Targeting human gastrointestinal stromal tumor cells with a quadruplex-binding small molecule. J Med Chem , 52 (12) 3774 - 3783. 10.1021/jm900424a.

Gupta, R; Vyas, P; Enver, T; (2009) Molecular Targeting of Cancer Stem Cells. CELL STEM CELL , 5 (2) 125 - 126. 10.1016/j.stem.2009.07.006.

H

Hadjur, S; Bruno, L; Hertweck, A; Cobb, BS; Taylor, B; Fisher, AG; Merkenschlager, M; (2009) IL4 blockade of inducible regulatory T cell differentiation: The role of Th2 cells, Gata3 and PU.1. IMMUNOL LETT , 122 (1) 37 - 43. 10.1016/j.imlet.2008.11.001.

Hadjur, S; Williams, LM; Ryan, NK; Cobb, BS; Sexton, T; Fraser, P; ... Merkenschlager, M; + view all (2009) Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus. NATURE , 460 (7253) 410 - U130. 10.1038/nature08079.

Hancock, BW; Qian, WD; Linch, D; Delchier, JC; Smith, P; Jakupovic, I; ... Zucca, E; + view all (2009) Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial. BRIT J HAEMATOL , 144 (3) 367 - 375. 10.1111/j.1365-2141.2008.07486.x.

Harland, SJ; Welch, R; Huddart, R; Stenning, S; Pollock, P; Gabe, R; (2009) On the necessity for postchemotherapy surgery for residual abdominal masses in metastatic nonseminomatous germ cell tumors (NSGCT) of testis. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Henriquez, N; Jacques, TS; Swales, A; Brandner, S; (2009) Stem cells, progenitor cells and brain tumours: how related are they? In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 4 - 4). BLACKWELL PUBLISHING

Hergovich, A; Hemmings, BA; (2009) Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling. BIOFACTORS , 35 (4) 338 - 345. 10.1002/biof.47.

Hergovich, A; Kohler, RS; Schmitz, D; Vichalkovski, A; Cornils, H; Hemmings, BA; (2009) The MST1 and hMOB1 Tumor Suppressors Control Human Centrosome Duplication by Regulating NDR Kinase Phosphorylation. CURR BIOL , 19 (20) 1692 - 1702. 10.1016/j.cub.2009.09.020.

Hersh, CP; Hansel, NN; Barnes, KC; Lomas, DA; Pillai, SG; Coxson, HO; ... ICGN Investigators,; + view all (2009) Transforming growth factor-beta receptor-3 is associated with pulmonary emphysema. Am J Respir Cell Mol Biol , 41 (3) 324 - 331. 10.1165/rcmb.2008-0427OC.

Hillmen, P; Gribben, JG; Follows, GA; Milligan, DW; Sayala, HA; Moreton, P; ... Pocock, C; + view all (2009) An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL). In: BLOOD. (pp. 1331 - 1332). AMER SOC HEMATOLOGY

Hochhauser, D; Meyer, T; Spanswick, VJ; Wu, J; Clingen, PH; Loadman, P; ... Jodrell, D; + view all (2009) Phase I Study of Sequence-Selective Minor Groove DNA Binding Agent SJG-136 in Patients with Advanced Solid Tumors. CLIN CANCER RES , 15 (6) 2140 - 2147. 10.1158/1078-0432.CCR-08-1315.

Holdsworth, R; Hurley, CK; Marsh, SGE; Lau, M; Noreen, HJ; Kempenich, JH; ... Maiers, M; + view all (2009) The HLA dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. 95 - 170.

Hoskin, PJ; Lowry, L; Horwich, A; Jack, A; Mead, B; Hancock, BW; ... Johnson, PWM; + view all (2009) Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 5390 - 5396). AMER SOC CLINICAL ONCOLOGY

Howard, PW; Chen, Z; Gregson, SJ; Masterson, L; Tiberghien, AC; Cooper, N; ... Thurston, DE; + view all (2009) Synthesis of a novel C2/C2?-aryl-substituted pyrrolo[2,1-c][1,4]benzodiazepine dimer prodrug with improved water solubility and reduced DNA reaction rate. Biorganic and Medicinal Chemistry Letters , 19 (22) 6463 - 6466. 10.1016/j.bmcl.2009.09.012.

Howe, C; Garstka, M; Al-Balushi, M; Ghanem, E; Antoniou, AN; Fritzsche, S; ... Springer, S; + view all (2009) Calreticulin-dependent recycling in the early secretory pathway mediates optimal peptide loading of MHC class I molecules. EMBO J , 28 (23) 3730 - 3744. 10.1038/emboj.2009.296.

Howie, AJ; Brewer, DB; (2009) Optical properties of amyloid stained by Congo red: history and mechanisms. Micron , 40 (3) 285 - 301. 10.1016/j.micron.2008.10.002.

Hubacek, P; Virgili, A; Ward, KN; Pohlreich, D; Keslova, P; Goldova, B; ... Cetkovsky, P; + view all (2009) HHV-6 DNA throughout the tissues of two stem cell transplant patients with chromosomally integrated HHV-6 and fatal CMV pneumonitis. BRIT J HAEMATOL , 145 (3) 394 - 398. 10.1111/j.1365-2141.2009.07622.x.

Hubbard, TJ; Aken, BL; Ayling, S; Ballester, B; Beal, K; Bragin, E; ... Flicek, P; + view all (2009) Ensembl 2009. Nucleic Acids Res , 37 (Database issue) D690 - D697. 10.1093/nar/gkn828. Gold open access

Huggett, JF; Taylor, MS; Kocjan, G; (2009) Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients (vol 63, pg 154, 2008). THORAX , 64 (7) 643 - 643.

Hughes, D; (2009) The Management of Gaucher Disease as a Chronic Disorder. In: CLINICAL THERAPEUTICS. (pp. S182 - S182). ELSEVIER

Hughes, DA; (2009) Enzyme, substrate, and myeloma in Gaucher Disease. AM J HEMATOL , 84 (4) 199 - 201. 10.1002/ajh.21375.

I

Iatan, I; Bailey, D; Hafiane, A; Zanesi, N; Taccioli, C; Abu Odeh, M; ... Genest, J; + view all (2009) Deficiency of the WW Domain-Containing Oxidoreductase (WWOX) Impairs the HDL Biogenesis Pathway. In: CIRCULATION. (pp. S476 - S477). LIPPINCOTT WILLIAMS & WILKINS

Isgro, G; Colvaruso, V; Manousou, P; Luong, TV; Andreana, L; Patch, DW; ... Burroughs, AK; + view all (2009) CORRELATION OF ISHAK STAGE,TRANSIENT ELASTOGRAPHY,HVPG AND COLLAGEN PROPORTIONATE AREA IN HCV TRANSPLANTED PATIENTS. In: HEPATOLOGY. (pp. 481A - 482A). JOHN WILEY & SONS INC

J

James, R; Wan, S; Glynne-Jones, R; Sebag-Montefiore, D; Kadalayil, L; Northover, J; ... NCRI ACT II Trial Management Grp,; + view all (2009) A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II). In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Jenner, RG; Townsend, MJ; Jackson, I; Sun, KM; Bouwman, RD; Young, RA; ... Lord, GM; + view all (2009) The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes. P NATL ACAD SCI USA , 106 (42) 17876 - 17881. 10.1073/pnas.0909357106. Gold open access

Jennings, B; Harvey, R; Ish-Horowicz, D; (2009) Regulation of transcriptional elongation by spt5 during drosophila development. In: MECHANISMS OF DEVELOPMENT. (pp. S114 - S114). ELSEVIER SCIENCE BV

Joly, P; Jennings, BH; Jayasinghe, SN; (2009) Development and fertility studies on post-bio-electrosprayed Drosophila melanogaster embryos. BIOMICROFLUIDICS , 3 (4) , Article 044107. 10.1063/1.3267044.

K

Kanhere, A; Vingron, M; (2009) Horizontal Gene Transfers in prokaryotes show differential preferences for metabolic and translational genes. BMC EVOL BIOL , 9 , Article 9. 10.1186/1471-2148-9-9. Green open access
file

Kaput, J; Cotton, RG; Hardman, L; Watson, M; Al Aqeel, AI; Al-Aama, JY; ... Yeom, YI; + view all (2009) Planning the human variome project: the Spain report. 496 - 510.

Kashima, TG; Halai, DD; Tirabosco, R; Hing, S; Ye, H; Flanagan, AM; (2009) An Audit of Lipomatous Neoplasms: Correlation with MDM2 Amplification by Fluorescence In Situ Hybridisation. In: LABORATORY INVESTIGATION. (pp. 15A - 15A). NATURE PUBLISHING GROUP

Kashima, TG; Halai, DD; Tirabosco, R; Hing, S; Ye, H; Flanagan, AM; (2009) An Audit of Lipomatous Neoplasms: Correlation with MDM2 Amplification by Fluorescence In Situ Hybridisation. In: MODERN PATHOLOGY. (pp. 15A - 15A). NATURE PUBLISHING GROUP

Kelleher, MT; Fruhwirth, G; Patel, G; Ofo, E; Festy, F; Barber, PR; ... Ng, T; + view all (2009) The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients. Target Oncol , 4 (3) 235 - 252. 10.1007/s11523-009-0116-y.

Khorashad, JS; Wagner, S; Greener, L; Marin, D; Reid, A; Milojkovic, D; ... Foroni, L; + view all (2009) The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib. Haematologica , 94 (6) 861 - 864. 10.3324/haematol.2008.003715.

Kim, BS; Miyagawa, F; Cho, YH; Bennett, CL; Clausen, BE; Katz, SI; (2009) Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis. J Invest Dermatol , 129 (12) 2805 - 2817. 10.1038/jid.2009.176.

Kimpfler, S; Sevko, A; Ring, S; Falk, C; Osen, W; Frank, K; ... Umansky, V; + view all (2009) Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs. J Immunol , 183 (10) 6330 - 6337. 10.4049/jimmunol.0900609.

Kirk, P; Roughton, M; Porter, JB; Walker, JM; Tanner, MA; Patel, J; ... Pennell, DJ; + view all (2009) Cardiac T2*Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major. CIRCULATION , 120 (20) 1961 - U23. 10.1161/CIRCULATIONAHA.109.874487.

Kirwan, M; Beswick, R; Vulliamy, T; Nathwani, AC; Walne, AJ; Casimir, C; Dokal, I; (2009) Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients. BRIT J HAEMATOL , 144 (5) 771 - 781. 10.1111/j.1365-2141.2008.07516.x.

Kishnani, PS; DiRocco, M; Kaplan, P; Mehta, A; Pastores, GM; Smith, SE; ... Lemay, RMWNJ; + view all (2009) A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1. Molecular genetics and metabolism 10.1016/j.ymgme.2008.12.015.

Kitoh, A; Ono, M; Naoe, Y; Ohkura, N; Yamaguchi, T; Yaguchi, H; ... Sakaguchi, S; + view all (2009) Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity , 31 (4) 609 - 620. 10.1016/j.immuni.2009.09.003.

Klanrit, P; Taebunpakul, P; Flinterman, MB; Odell, EW; Riaz, MA; Melino, G; ... Tavassoli, M; + view all (2009) PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers. ONCOGENE , 28 (39) 3499 - 3512. 10.1038/onc.2009.191.

Knight, A; Mackinnon, S; Lowdell, MW; (2009) CMV-Reactive Gamma/Delta T Cells Expanded From CMV Seronegative Normal Healthy Individuals Lyse CMV-Infected Targets - Potential Adoptive Immunotherapy for Recipients of Stem Cell Transplants From CMV Seronegative Donors. In: BLOOD. (pp. 880 - 880). AMER SOC HEMATOLOGY

Knight, SJL; Akha, ES; Timbs, A; Enver, T; Pettitt, AR; Taylor, J; ... Schuh, A; + view all (2009) Identification of Novel Recurrent Copy Number Variations and Regions of Copy-Neutral Loss of Heterozygosity by High Resolution Genomic Array in Pre-Treatment and Relapsed B-CLL. In: BLOOD. (pp. 451 - 451). AMER SOC HEMATOLOGY

Kocjan, G; Chandra, A; Cross, P; Denton, K; Giles, T; Herbert, A; ... Wilson, P; + view all (2009) BSCC Code of Practice - fine needle aspiration cytology. CYTOPATHOLOGY , 20 (5) 283 - 296. 10.1111/j.1365-2303.2009.00709.x.

Kocjan, G; Ramsay, A; Beale, T; O'Flynn, P; (2009) Head and neck cancer in the UK: what is expected of cytopathology? CYTOPATHOLOGY , 20 (2) 69 - 77. 10.1111/j.1365-2303.2009.00647.x.

Kok, K; Geering, B; Vanhaesebroeck, B; (2009) Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci , 34 (3) 115 - 127. 10.1016/j.tibs.2009.01.003.

Kok, K; Nock, GE; Verrall, EA; Mitchell, MP; Hommes, DW; Peppelenbosch, MP; Vanhaesebroeck, B; (2009) Regulation of p110δ PI 3-Kinase Gene Expression. PLoS One , 4 (4) , Article e5145. 10.1371/journal.pone.0005145. Green open access
file

Kong, X; Coxson, H; Lomas, DA; Silverman, EK; Pillai, SG; Investigators, ECLIPSE; (2009) Genome-Wide Association Study (GWA) of High Resolution CT Defined Emphysema Phenotypes in Two Independent COPD Populations. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 179

Kranc, KR; Schepers, H; Rodrigues, NP; Bamforth, S; Villadsen, E; Ferry, H; ... Enver, T; + view all (2009) Cited2 Is an Essential Regulator of Adult Hematopoietic Stem Cells. CELL STEM CELL , 5 (6) 659 - 665. 10.1016/j.stem.2009.11.001.

Krishnamurthy, S; Shaw, BE; Byrne, J; Seedhouse, C; Mayor, N; Madrigal, JA; Russell, N; (2009) A caspase8 promoter polymorphism is associated with increased TRM and reduced survival following T-cell depleted unrelated donor transplantation using alemtuzumab. In: BONE MARROW TRANSPLANTATION. (pp. S79 - S80). NATURE PUBLISHING GROUP

Kristeleit, R; Calvert, H; Arkenau, H; Olmos, D; Adam, J; Plummer, ER; ... Judson, I; + view all (2009) A phase I study of AT9283, an aurora kinase inhibitor, in patients with refractory solid tumors. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Kroeger, H; Miranda, E; MacLeod, I; Pérez, J; Crowther, DC; Marciniak, SJ; Lomas, DA; (2009) Endoplasmic reticulum-associated degradation (ERAD) and autophagy cooperate to degrade polymerogenic mutant serpins. J Biol Chem , 284 (34) 22793 - 22802. 10.1074/jbc.M109.027102.

Kummar, S; Doroshow, JH; Tomaszewski, JE; Calvert, AH; Lobbezoo, M; Giaccone, G; Task Force MDICT,; (2009) Phase 0 clinical trials: Recommendations from the task force on methodology for the development of innovative cancer therapies. EUR J CANCER , 45 (5) 741 - 746. 10.1016/j.ejca.2008.10.024.

Kwiatkowski, JL; Kim, HY; Thompson, AA; Quinn, CT; Mueller, BU; Odame, I; ... Neufeld, EJ; + view all (2009) Chelation Choices and Iron Burden Among Patients with Thalassemia in the 21st Century: a Report From the Thalassemia Clinical Research Network (TCRN) Longitudinal Cohort. In: BLOOD. (pp. 1555 - 1556). AMER SOC HEMATOLOGY

L

Lajiness, J; Sielaff, A; MacKay, H; Brown, T; Kluza, J; Nguyen, B; ... Hartley, JA; + view all (2009) Polyamide Curvature and DNA Sequence Selective Recognition: Use of 4-Aminobenzamide to Adjust Curvature. MED CHEM , 5 (3) 216 - 226.

Lambert, J; Linch, DC; Gale, RE; (2009) MULTIPLE JAK2 V617F MUTATIONS ARE PRESENT IN MOST PATIENTS WITH ESSENTIAL THROMBOCYTHAEMIA: A NEW DISEASE PARADIGM. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 421 - 421). FERRATA STORTI FOUNDATION Gold open access

Lawrenson, K; Benjamin, E; Turmaine, M; Jacobs, I; Gayther, S; Dafou, D; (2009) In vitro three-dimensional modelling of human ovarian surface epithelial cells. CELL PROLIFERAT , 42 (3) 385 - 393. 10.1111/j.1365-2184.2009.00604.x.

Leclerc, X; Danos, O; Scherman, D; Kichler, A; (2009) A comparison of synthetic oligodeoxynucleotides, DNA fragments and AAV-1 for targeted episomal and chromosomal gene repair. BMC Biotechnol , 9 35 - ?. 10.1186/1472-6750-9-35.

Ledermann, JA; Rustin, GJ; Hackshaw, A; Kaye, SB; Jayson, G; Gabra, H; ... Temple, G; + view all (2009) A randomized phase II placebo-controlled trial using maintenance therapy to evaluate the vascular targeting agent BIBF 1120 following treatment of relapsed ovarian cancer (OC). In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Ledermann, JA; Stebbing, J; (2009) Positioning pemetrexed in the treatment of ovarian cancer. EUR J CANCER , 45 (8) 1330 - 1332. 10.1016/j.ejca.2009.02.006.

Lee, CA; Chi, C; Shiltagh, N; Pollard, D; Griffioen, A; Dunn, N; Kadir, RA; (2009) Review of a multidisciplinary clinic for women with inherited bleeding disorders. HAEMOPHILIA , 15 (1) 359 - 360. 10.1111/j.1365-2516.2008.01824.x.

Lee, SM; James, LE; Qian, W; Spiro, S; Eisen, T; Gower, NH; ... Rudd, RM; + view all (2009) Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer. Thorax , 64 (1) 75 - 80. 10.1136/thx.2007.093872.

Lee, SM; Rudd, R; Woll, PJ; Ottensmeier, C; Gilligan, D; Price, A; ... Hackshaw, A; + view all (2009) Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and Carboplatin in advanced non-small-cell lung cancer. J Clin Oncol , 27 (31) 5248 - 5254. 10.1200/JCO.2009.21.9733.

Lee, SM; Woll, PJ; Rudd, R; Ferry, D; O'Brien, M; Middleton, G; ... Hackshaw, A; + view all (2009) Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst , 101 (15) 1049 - 1057. 10.1093/jnci/djp200. Green open access
file

Leedham, SJ; Graham, TA; Oukrif, D; McDonald, SAC; Rodriguez-Justo, M; Harrison, RF; ... Wright, NA; + view all (2009) Clonality, Founder Mutations, and Field Cancerization in Human Ulcerative Colitis-Associated Neoplasia. GASTROENTEROLOGY , 136 (2) 542 - 550. 10.1053/j.gastro.2008.10.086.

Leitner, S; Sweeney, K; Oberg, D; Davies, D; Miranda, E; Lemoine, NR; Hallden, G; (2009) Oncolytic Adenoviral Mutants with E1B19K Gene Deletions Enhance Gemcitabine-induced Apoptosis in Pancreatic Carcinoma Cells and Anti-Tumor Efficacy In vivo. Clinical Cancer Research , 15 (5) 1730 - 1740. 10.1158/1078-0432.CCR-08-2008.

Lhériteau, E; Libeau, L; Stieger, K; Deschamps, JY; Mendes-Madeira, A; Provost, N; ... Rolling, F; + view all (2009) The RPGRIP1-deficient dog, a promising canine model for gene therapy. Mol Vis , 15 349 - 361.

Li, W; Ferguson, BJ; Khaled, WT; Tevendale, M; Stingl, J; Poli, V; ... Watson, CJ; + view all (2009) PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. P NATL ACAD SCI USA , 106 (12) 4725 - 4730. 10.1073/pnas.0807640106.

Liu, D; Zhang, T; Marshall, AJ; Okkenhaug, K; Vanhaesebroeck, B; Uzonna, JE; (2009) The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J Immunol , 183 (3) 1921 - 1933. 10.4049/jimmunol.0901099.

Liu, ML; Liu, MJ; Shen, YF; Ryu, H; Kim, HJ; Klupsch, K; ... Hong, ST; + view all (2009) Omi is a mammalian heat-shock protein that selectively binds and detoxifies oligomeric amyloid-beta. J CELL SCI , 122 (11) 1917 - 1926. 10.1242/jcs.042226.

Lolkema, MP; Harrington, K; Evans, J; Arkenau, HT; Roxburgh, P; Morrison, R; ... de Bono, J; + view all (2009) A phase-I study of the combination of intravenous reovirus (REOLYSIN (R)) and gemcitabine in patients with advanced cancer. In: EJC SUPPLEMENTS. (pp. 131 - 131).

Lomas, DA; Silverman, EK; Edwards, LD; Locantore, NW; Miller, BE; Horstman, DH; ... Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study investigators,; + view all (2009) Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J , 34 (1) 95 - 102. 10.1183/09031936.00156508.

Lomas, DA; Silverman, EK; Edwards, LD; Miller, BE; Tal-Singer, R; Investigators, ECLIPSE; (2009) Serum Surfactant Protein D Is Associated with Exacerbations of COPD. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 179

Lopez, MN; Pereda, C; Segal, G; Munoz, L; Aguilera, R; Gonzalez, FE; ... Salazar-Onfray, F; + view all (2009) Prolonged Survival of Dendritic Cell-Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor beta-Expressing T Cells. J CLIN ONCOL , 27 (6) 945 - 952. 10.1200/JCO.2008.18.0794.

Lorenz, A; Osman, F; Folkyte, V; Sofueva, S; Whitby, MC; (2009) Fbh1 Limits Rad51-Dependent Recombination at Blocked Replication Forks. MOL CELL BIOL , 29 (17) 4742 - 4756. 10.1128/MCB.00471-09.

Lucas, A; Liu, L; Dai, E; Bot, I; Viswanathan, K; Munuswamy-Ramunujam, G; ... McFadden, G; + view all (2009) The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics. Adv Exp Med Biol , 666 132 - 156.

Lugli, E; Ferraresi, R; Roat, E; Troiano, L; Pinti, M; Nasi, M; ... Cossarizza, A; + view all (2009) Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells. LEUKEMIA RES , 33 (1) 140 - 150. 10.1016/j.leukres.2008.07.025.

Lynch, S; Santos, SG; Campbell, EC; Nimmo, AMS; Botting, C; Prescott, A; ... Powis, SJ; + view all (2009) Novel MHC Class I Structures on Exosomes. J IMMUNOL , 183 (3) 1884 - 1891. 10.4049/jimmunol.0900798.

M

Mackall, C; Fry, T; Gress, R; Peggs, K; Storek, J; Toubert, A; (2009) Background to hematopoietic cell transplantation, including post transplant immune recovery. BONE MARROW TRANSPL , 44 (8) 457 - 462. 10.1038/bmt.2009.255.

Mahendran, AO; Elvey, M; Howie, AJ; Dupont, P; Veitch, PS; (2009) Early Renal Transplant Protocol Biopsies Directly Influence Patient Management. In: AMERICAN JOURNAL OF TRANSPLANTATION. (pp. 213 - 213). WILEY-BLACKWELL PUBLISHING, INC

Mahendran, AO; Elvey, M; Mahendran, M; Howie, AJ; Dupont, P; Veitch, PS; (2009) EARLY RENAL TRANSPLANT PROTOCOL BIOPSIES DIRECTLY INFLUENCE PATIENT MANAGEMENT. TRANSPL INT , 22 16 - 16.

Mahendran, AO; Haroon, S; Dupont, PJ; Howie, A; Veitch, PS; (2009) AN INCREMENTAL INCREASE IN CHRONIC ALLOGRAFT DAMAGE DETECTED ON PROTOCOL BIOPSIES DURING THE FIRST YEAR POST-TRANSPLANTATION. TRANSPL INT , 22 260 - 260.

Makrogianneli, K; Carlin, LM; Keppler, MD; Matthews, DR; Ofo, E; Coolen, A; ... Ng, T; + view all (2009) Integrating Receptor Signal Inputs That Influence Small Rho GTPase Activation Dynamics at the Immunological Synapse. Molecular and Cellular Biology , 29 (11) 2997 - 3006. 10.1128/MCB.01008-08.

Malladi, R; Sloane-Stanley, J; Gupta, R; Rodrigues, N; Wood, W; Enver, T; (2009) THE EFFECT OF THE TEL-TRKC ONCOGENE ON THE HAEMATO-ENDOTHELIAL DIFFERENTIATION FROM HUMAN EMBRYONIC STEM CELLS. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 2 - 2). FERRATA STORTI FOUNDATION Gold open access

Mamopoulos, AM; Hughes, DA; Tuck, SMMAB; (2009) Gaucher disease and pregnancy. Journal of Obstetrics and Gynaecology , 29 (3) 240 - 251. 10.1080/01443610902754398.

Mansour, MR; (2009) Oncogenic Kras and Notch-1 cooperate in T-cell acute lymphoblastic leukemia/lymphoma. Expert Rev Hematol , 2 (2) 133 - 136. 10.1586/ehm.09.3.

Mantovani, J; Charrier, S; Eckenberg, R; Saurin, W; Danos, O; Perea, J; Galy, A; (2009) Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott-Aldrich syndrome. J Gene Med , 11 (8) 645 - 654. 10.1002/jgm.1346.

Manuel, O; Asberg, A; Pang, XL; Rollag, H; Emery, VC; Preiksaitis, JK; ... Humar, A; + view all (2009) Impact of Genetic Polymorphisms in Cytomegalovirus Glycoprotein B on Outcomes in Solid-Organ Transplant Recipients with Cytomegalovirus Disease. CLIN INFECT DIS , 49 (8) 1160 - 1166. 10.1086/605633.

Marciniak, SJ; Lomas, DA; (2009) What can naturally occurring mutations tell us about the pathogenesis of COPD? Thorax , 64 (4) 359 - 364. 10.1136/thx.2008.099408.

Marks, DI; Paietta, EM; Moorman, AV; Richards, SM; Buck, G; DeWald, G; ... Lazarus, HM; + view all (2009) T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). BLOOD , 114 (25) 5136 - 5145. 10.1182/blood-2009-08-231217.

Martín Caballero, I; Hansen, J; Leaford, D; Pollard, S; Hendrich, BD; (2009) The methyl-CpG binding proteins Mecp2, Mbd2 and Kaiso are dispensable for mouse embryogenesis, but play a redundant function in neural differentiation. PLoS One , 4 (1) , Article e4315 . 10.1371/journal.pone.0004315. Green open access
file

Mattar, CN; Dighe, NM; Waddington, SN; McIntosh, J; Biswas, A; Fisk, NM; ... Chan, J; + view all (2009) Long-Term Transgene Expression in New-Born Cynomolgus Macaques Following Intra-Uterine Gene Transfer of Self-Complementary AAV. In: MOLECULAR THERAPY. (pp. S117 - S117). NATURE PUBLISHING GROUP

Mayor, N; Shaw, BE; Cooke, L; Marsh, S; Madrigal, JA; (2009) The impact of NOD2/CARD15 SNP 5 on the outcome of unrelated donor haematopoietic stem cell transplantation for acute lymphoblastic leukaemia. In: BONE MARROW TRANSPLANTATION. (pp. S203 - S203). NATURE PUBLISHING GROUP

Mayor, NP; Shaw, BE; Cooke, L; Madrigal, JA; Marsh, SGE; (2009) Predicting disease relapse using NOD2/CARD15 SNP5 and HLA-DPB1 matching status. INT J IMMUNOGENET , 36 (5) 317 - 318.

Mayor, NP; Shaw, BE; Cooke, L; Madrigal, JA; Marsh, SGE; (2009) The impact of NOD2/CARD15 SNP 5 on the outcome of unrelated donor hematopoietic stem cell transplantation for acute lymphoblastic leukaemia. In: TISSUE ANTIGENS. (pp. 403 - 403). WILEY-BLACKWELL PUBLISHING, INC

McCabe, DJH; Starke, R; Harrison, P; Brown, MM; Sidhu, PS; Mackie, IJ; Machin, SJ; (2009) ADAMTS-13 (VON WILLEBRAND FACTOR-CLEAVING PROTEASE) ACTIVITY IN THE EARLY AND LATE PHASES AFTER TRANSIENT ISCHAEMIC ATTACK OR ISCHAEMIC STROKE. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 103 - 104). B M J PUBLISHING GROUP

McCabe, N; Cerone, MA; Ohishi, T; Seimiya, H; Lord, CJ; Ashworth, A; (2009) Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer. Oncogene , 28 (11) 1465 - 1470. 10.1038/onc.2008.483.

McGovern, UB; Francis, RE; Peck, B; Guest, SK; Wang, J; Myatt, SS; ... Lam, EW; + view all (2009) Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer. Mol Cancer Ther , 8 (3) 582 - 591. 10.1158/1535-7163.MCT-08-0805.

McGovern, UB; Stebbing, J; (2009) Receptor-based predictors of response in breast cancer. [Editorial comment]. Future Oncology , 5 (3) 283 - 286. 10.2217/fon.09.1. Green open access
file

Mednick, L; Yu, SL; Trachtenberg, F; Kleinert, DA; Giardina, PJ; Kwiatkowski, JL; ... Yamashita, R; + view all (2009) Symptoms of Anxiety and Depression Among Teens and Adults in the Thalassemia Longitudinal Cohort Study. In: BLOOD. (pp. 231 - 232). AMER SOC HEMATOLOGY

Meng, S; Arbit, T; Veeriah, S; Mellinghoff, IK; Fang, F; Vivanco, I; ... Chan, TA; + view all (2009) 14-3-3sigma and p21 synergize to determine DNA damage response following Chk2 inhibition. Cell Cycle , 8 (14) 2238 - 2246.

Michelagnoli, M; Kotecha, K; Anazado, A; Flanagan, A; Tirabosco, R; Briggs, T; ... Whelan, J; + view all (2009) OUTLOOK FOR CHILDREN UNDER 13 YEARS WITH PRIMARY MALIGNANT BONE TUMOURS - THE LONDON SARCOMA SERVICE EXPERIENCE 1999-2009. PEDIATR BLOOD CANCER , 53 (5) 797 - 798.

Middleton, D; Gonzalez, F; Fernandez-Vina, M; Tiercy, JM; Marsh, SGE; Aubrey, M; ... Yang, KL; + view all (2009) A bioinformatics approach to ascertaining the rarity of HLA alleles. 480 - 485.

Miene, C; Klenow, S; Veeriah, S; Richling, E; Glei, M; (2009) Impact of apple polyphenols on GSTT2 gene expression, subsequent protection of DNA and modulation of proliferation using LT97 human colon adenoma cells. Mol Nutr Food Res , 53 (10) 1254 - 1262. 10.1002/mnfr.200800444.

Miller, K; Ibrahim, M; Herriot, K; (2009) The UK NEQAS online auditing system for breast cancer predictive markers. VIRCHOWS ARCH , 455 75 - 75.

Mischerikow, N; Spedale, G; Altelaar, AF; Timmers, HT; Pijnappel, WW; Heck, AJ; (2009) In-depth profiling of post-translational modifications on the related transcription factor complexes TFIID and SAGA. J Proteome Res , 8 (11) 5020 - 5030. 10.1021/pr900449e.

Mohamedbhai, SG; Lowry, L; Goldstone, AH; Linch, DC; Ardeshna, KM; (2009) Rituximab in combination with CODOX-M/IVAC: toxicity and efficacy in 17 adults with non-HIV related B-cell non-Hodgkin lymphomas with 495% proliferation index. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 15 - 16). WILEY-BLACKWELL PUBLISHING, INC

Moilanen, P; Korppi, M; Hovi, L; Chapgier, A; Feinberg, J; Kong, XF; ... Saarinen-Pihkala, UM; + view all (2009) Successful hematopoietic stem cell transplantation from an unrelated donor in a child with interferon gamma receptor deficiency. Pediatr Infect Dis J , 28 (7) 658 - 660. 10.1097/INF.0b013e318195092e.

Moisoi, N; Klupsch, K; Fedele, V; East, P; Sharma, S; Renton, A; ... Martins, LM; + view all (2009) Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. CELL DEATH DIFFER , 16 (3) 449 - 464. 10.1038/cdd.2008.166.

Morris, JR; Densham, R; Weekes, D; Alamshah, A; Butler, L; Pangon, L; ... Galanty, Y; + view all (2009) The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature , 462 (7275) 886 - 890. 10.1038/nature08593.

Morris, T; Kettle, P; Drake, M; Quinn, M; Cavet, J; Tighe, J; ... Popat, R; + view all (2009) Second Autologous Transplantation After Bortezomib-Based Re-induction Therapy: The UK Experience. CLIN LYMPHOMA MYELOM , 9 S40 - S41.

Morris, T; Oakervee, H; Kettle, P; Drake, M; Brunton, A; Cook, G; ... Cavenagh, J; + view all (2009) The PAD (Ireland) Study for Patients with Refractory and Relapsed Myeloma: An Update. CLIN LYMPHOMA MYELOM , 9 S27 - S27.

Morris, TCM; Kettle, P; Drake, M; Brunton, A; Cook, G; Leahy, M; ... Cavenagh, J; + view all (2009) Bortezomib, adriamycin and dexamethasone for patients with refractory and relapsed myeloma - results from the PAD (Ireland) study. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 16 - 16). WILEY-BLACKWELL PUBLISHING, INC

Morris, TCM; Kettle, P; Drake, M; Quinn, M; Cavet, J; Tighe, J; ... Popat, R; + view all (2009) Good response rates following second autologous transplantation after bortezomib-based re-induction therapy. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 87 - 87). WILEY-BLACKWELL PUBLISHING, INC

Mulder, K; Westrate, L; Brown, T; Mackay, H; Chavda, S; Babu, B; ... Lee, M; + view all (2009) DNA sequence selective recognition by the pyrrole(H)/N-methylpyrrole and pyrrole(H)/N-methylimidazole: Design, synthesis, and biophysical characteristics. ABSTR PAP AM CHEM S , 238 ? - ?.

Murugaesu, N; Powles, T; Bestwick, J; Oliver, RT; Shamash, J; (2009) Long-term follow-up of testicular cancer patients shows no predisposition to osteoporosis. Osteoporos Int , 20 (9) 1627 - 1630. 10.1007/s00198-008-0793-x.

Mustapa, MFM; Grosse, SM; Kudsiova, L; Elbs, M; Raiber, EA; Wong, JB; ... Tabor, AB; + view all (2009) Stabilized Integrin-Targeting Ternary LPD (Lipopolyplex) Vectors for Gene Delivery Designed To Disassemble Within the Target Cell. BIOCONJUGATE CHEM , 20 (3) 518 - 532. 10.1021/bc800450r.

N

Nagao, K; Ginhoux, F; Leitner, WW; Motegi, S; Bennett, CL; Clausen, BE; ... Udey, MC; + view all (2009) Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci U S A , 106 (9) 3312 - 3317. 10.1073/pnas.0807126106.

Nathwani, AC; Cochrane, M; McIntosh, J; Ng, CYC; Zhou, J; Gray, JT; Davidoff, AM; (2009) Enhancing transduction of the liver by adeno-associated viral vectors. GENE THER , 16 (1) 60 - 69. 10.1038/gt.2008.137.

Nerelius, C; Sandegren, A; Sargsyan, H; Raunak, R; Leijonmarck, H; Chatterjee, U; ... Johansson, J; + view all (2009) Alpha-helix targeting reduces amyloid-beta peptide toxicity. Proc Natl Acad Sci U S A , 106 (23) 9191 - 9196. 10.1073/pnas.0810364106.

Ng, T; Boguslavsky, SK; Tarcic, G; Wakim, J; Kiuchi, T; Liu, A; ... Nathanson, D; + view all (2009) An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR Endocytosis. Current Biology , 19 (21) 1788 - 1798. 10.1016/j.cub.2009.09.048.

Nikitenko, LL; (2009) Vascular endothelium in cancer. CELL TISSUE RES , 335 (1) 223 - 240. 10.1007/s00441-008-0707-4.

Novakovic, B; Sibson, M; Ng, HK; Manuelpillai, U; Rakyan, V; Down, T; ... Saffery, R; + view all (2009) Placenta-specific methylation of the vitamin d 24-hydroxylase gene implications for feedback autoregulation of active vitamin d levels at the fetomaternal interface. The journal of biological chemistry , 284 (22) 14838 - 14848. 10.1074/jbc.M809542200. Green open access
file

O

O' Reilly, LA; Tai, L; Lee, L; Kruse, EA; Grabow, S; Fairlie, WD; ... Strasser, A; + view all (2009) Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature , 461 (7264) 659 - 663. 10.1038/nature08402.

Ogilvie, R; Plaunt, A; Riddering, C; Westrate, L; Davis, R; Ferguson, A; ... Lee, M; + view all (2009) ORGN 339-Design, synthesis and DNA binding properties of orthogonally positioned diamino-containing polyamides. ABSTR PAP AM CHEM S , 237 ? - ?.

Olmos, D; Arkenau, HT; Ang, JE; Ledaki, I; Attard, G; Carden, CP; ... de Bono, JS; + view all (2009) Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. Ann Oncol , 20 (1) 27 - 33. 10.1093/annonc/mdn544.

Ooi, SKT; O'Donnell, AH; Bestor, TH; (2009) Mammalian cytosine methylation at a glance. J CELL SCI , 122 (16) 2787 - 2791. 10.1242/jcs.015123.

Ors, A; Grimaldi, M; Kimata, Y; Wilkinson, CR; Jones, N; Yamano, H; (2009) The transcription factor Atf1 binds and activates the APC/C ubiquitin ligase in fission yeast. J. Biol. Chem. , 284 (36) 23989 - 23994. Gold open access

P

Pacey, SC; Wilson, R; Walton, M; Eatock, M; Zetterlund, A; Arkenau, H; ... Judson, I; + view all (2009) A phase I trial of the HSP90 inhibitor, alvespimycin (17-DMAG) administered weekly, intravenously, to patients with advanced, solid tumours. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Panasyuk, G; Nemazanyy, I; Zhyvoloup, A; Filonenko, V; Davies, D; Robson, M; ... Gout, I; + view all (2009) mTOR beta Splicing Isoform Promotes Cell Proliferation and Tumorigenesis. J BIOL CHEM , 284 (45) 30807 - 30814. 10.1074/jbc.M109.056085. Gold open access

Pankhurst, T; Lepenies, J; Nightingale, P; Howie, AJ; Adu, D; Harper, L; (2009) Vasculitic IgA nephropathy: prognosis and outcome. Nephron Clin Pract , 112 (1) c16 - c24. 10.1159/000210570.

Papageorgiou, EA; Fiegler, H; Rakyan, V; Beck, S; Hulten, M; Lamnissou, K; ... Patsalis, PC; + view all (2009) Sites of Differential DNA Methylation between Placenta and Peripheral Blood Molecular Markers for Noninvasive Prenatal Diagnosis of Aneuploidies. AM J PATHOL , 174 (5) 1609 - 1618. 10.2353/ajpath.2009.081038.

Pastores, GM; Giraldo, P; Cherin, PMA; (2009) Goal-orientated therapy with Miglustat in Gaucher disease. Current Medical Research and Opinion , 25 (1) 23 - 37. 10.1185/03007990802576518.

Patel, B; Buck, G; Mortuza, Y; Rai, L; Mitchell, W; Gerrard, G; ... Foroni, L; + view all (2009) Minimal residual disease is a significant predictor of treatment failure in B lineage adult ALL: final results of the international trial UKALL XII:ECOG 2993. BRITISH JOURNAL OF HAEMATOLOGY , 145 44 - 44.

Patel, B; Ghorani, E; Zhang, Y; Gitendra-Wickremasinghe, R; Steele, A; Fielding, AK; (2009) Attenuated Measles Virus: A Promising Therapeutic Modality for B Cell Malignancy. In: BLOOD. (pp. 970 - 970). AMER SOC HEMATOLOGY

Patel, B; Kirkland, KE; Szydlo, R; Pearce, RM; Clark, RE; Craddock, C; ... Marks, DI; + view all (2009) Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission. HAEMATOL-HEMATOL J , 94 (10) 1399 - 1406. 10.3324/haematol.2009.008649. Gold open access

Paten, B; Herrero, J; Beal, K; Birney, E; (2009) Sequence progressive alignment, a framework for practical large-scale probabilistic consistency alignment. Bioinformatics , 25 (3) 295 - 301. 10.1093/bioinformatics/btn630.

Paulussen, M; Craft, A; Lewis, I; Hackshaw, A; Douglas, C; Whelan, J; Jurgens, HFDEICESSSG; (2009) Zwei randomisierte Ewing Sarkom Studien Schweizer Krebsbulletin. Bulletin suisse du cancer , 29 (2) 128 - 134.

Payne, E; Look, T; (2009) Zebrafish modelling of leukaemias. Br J Haematol , 146 (3) 247 - 256. 10.1111/j.1365-2141.2009.07705.x.

Pearce, S; Gibson, F; Eden, T; Glaser, A; Hooker, L; Whelan, J; Kelly, D; (2009) The experiences of young people from first symptoms to the diagnosis of cancer: a narrative study. In: European Journal of Cancer. (pp. 234 - ?).

Pearce, S; Gibson, F; Eden, TE; Glaser, A; Hooker, L; Whelan, J; Kelly, D; (2009) A narrative study of the experiences of young people from first symptoms to the diagnosis of cancer. In: National Cancer Research Institute Cancer Conference, 2009, Birmingham.

Peggs, KS; (2009) Adoptive T cell immunotherapy for cytomegalovirus. EXPERT OPIN BIOL TH , 9 (6) 725 - 736. 10.1517/14712590902967588.

Peggs, KS; Krauss, A; Mackall, C; (2009) Clinical implications of immune reconstitution following autologous and allogeneic transplantation. In: Bishop, MR, (ed.) Hematopoietic Stem Cell Transplantation. (131 - 154). Springer Verlag

Peggs, KS; Krauss, AC; Mackall, CL; (2009) Clinical implications of immune reconstitution following hematopoietic stem cell transplantation. Cancer Treat Res , 144 131 - 154. 10.1007/978-0-387-78580-6_6.

Peggs, KS; Quezada, SA; Allison, JP; (2009) Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists. CLIN EXP IMMUNOL , 157 (1) 9 - 19. 10.1111/j.1365-2249.2009.03912.x.

Peggs, KS; Quezada, SA; Chambers, CA; Korman, AJ; Allison, JP; (2009) Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J EXP MED , 206 (8) 1717 - 1725. 10.1084/jem.20082492.

Peggs, KS; Quezada, SA; Sharma, P; Allison, JP; (2009) Cancer immunotherapy. In: Hong, WK and Bast, RC and Hait, W and Kufe, DW and Pollock, RE and Holland, JF and Weichselbaum, RR, (eds.) Cancer medicine 8. (175 - 189). Pmph USA Ltd

Peggs, KS; Thomson, K; Samuel, E; Dyer, G; Armoogum, J; Pang, K; ... Lowdell, MW; + view all (2009) Adoptive Transfer of CMV-Specific Donor T Cells Following Allogeneic Transplantation Leads to Rapid and Safe Systemic Reconstitution. In: BLOOD. (pp. 24 - 24). AMER SOC HEMATOLOGY

Peggs, KS; Verfuerth, S; Pizzey, A; Chow, SLC; Thomson, K; Mackinnon, S; (2009) Cytomegalovirus-Specific T Cell Immunotherapy Promotes Restoration of Durable Functional Antiviral Immunity following Allogeneic Stem Cell Transplantation. CLIN INFECT DIS , 49 (12) 1851 - 1860. 10.1086/648422.

Pennell, D; El-Beshlawy, A; Sutcharitchan, P; Elalfy, M; Aydinok, Y; Taher, A; ... Porter, JB; + view all (2009) PREVENTION OF CARDIAC IRON ACCUMULATION WITH ONCE DAILY ORAL DEFERASIROX THERAPY IN REGULARLY TRANSFUSED PATIENTS WITH B THALASSAEMIA MAJOR. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 433 - 434). FERRATA STORTI FOUNDATION Gold open access

Pennell, D; Porter, JB; Cappellini, MD; Chan, LL; El-Beshlawy, A; Aydinok, Y; ... Taher, A; + view all (2009) EFFICACY AND SAFETY OF DEFERASIROX IN REDUCING MYOCARDIAL SIDEROSIS IN PATIENTS WITH B-THALASSAEMIA MAJOR. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 74 - 75). FERRATA STORTI FOUNDATION Gold open access

Pennell, DJ; Porter, JB; Cappellini, MD; Chan, LL; El-Beshlawy, A; Aydinok, Y; ... Taher, A; + view all (2009) Efficacy and Safety of Deferasirox (Exjade (R)) in beta-Thalassemia Patients with Myocardial Siderosis: 2-Year Results From the EPIC Cardiac Sub-Study. In: BLOOD. (pp. 1558 - 1558). AMER SOC HEMATOLOGY

Perera, G; Kassen, D; Nestle, F; (2009) A successful therapeutic model for psoriasis: recapitulation of human psoriasis in a xenotransplantation mouse model. In: BRITISH JOURNAL OF DERMATOLOGY. (pp. 10 - 10). WILEY-BLACKWELL PUBLISHING, INC

Perera, GK; Kassen, D; Nestle, FO; (2009) Investigation of the spatiotemporal expression pattern of the antimicrobial peptide, LL-37, in the development and resolution of psoriasis. In: BRITISH JOURNAL OF DERMATOLOGY. (pp. 904 - 904). WILEY-BLACKWELL PUBLISHING, INC

Peters, FH; Brunell, C; Benjamin, E; (2009) Massive ovarian edema and contralateral mature cystic teratoma: asymptomatic presentation in a premenarchal female. J Pediatr Adolesc Gynecol , 22 (5) e118 - e120. 10.1016/j.jpag.2008.09.005.

Pichiorri, F; Suh, SS; De Luca, L; Taccioli, C; Benson, D; Hofmeister, C; ... Croce, CM; + view all (2009) p53-Inducible Micrornas 192 and 215 Regulate p53 Expression and IGF1 Axis in Multiple Myeloma. In: BLOOD. (pp. 781 - 781). AMER SOC HEMATOLOGY

Pillai, SG; Ge, D; Zhu, G; Kong, X; Shianna, KV; Need, AC; ... ICGN Investigators,; + view all (2009) A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet , 5 (3) e1000421 . 10.1371/journal.pgen.1000421. Green open access
file

Pillai, SG; Kong, X; Coxson, H; Lomas, DA; Silverman, EK; Investigators, ECLIPSE; (2009) Association Analysis of Two Novel, Replicated COPD Susceptibility Genes in the ECLIPSE Cohort. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 179

Plummer, R; Hayward, L; Lorigan, P; Soriano, V; Moiseyenko, V; Szyldergemajn, S; ... Calvert, H; + view all (2009) Plitidepsin alone or with dacarbazine (DTIC) as first-line treatment for advanced unresectable melanoma (AUM). In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Plummer, R; Vidal, L; Griffin, M; Lesley, M; de Bono, J; Coulthard, S; ... Bloody, AV; + view all (2009) Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors. CLIN CANCER RES , 15 (9) 3177 - 3183. 10.1158/1078-0432.CCR-08-2859.

Pollard, SM; Stricker, SH; Beck, S; (2009) A Shore Sign of Reprogramming. CELL STEM CELL , 5 (6) 571 - 572. 10.1016/j.stem.2009.11.006.

Pollard, SM; Yoshikawa, K; Clarke, ID; Danovi, D; Stricker, S; Russell, R; ... Dirks, P; + view all (2009) Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens. CELL STEM CELL , 4 (6) 568 - 580. 10.1016/j.stem.2009.03.014.

Popat, R; Oakervee, H; Williams, C; Cook, M; Craddock, C; Basu, S; ... Cavenagh, J; + view all (2009) Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , 144 (6) 887 - 894. 10.1111/j.1365-2141.2008.07572.x.

Porter, J; (2009) Blood transfusion: quality and safety issues in thalassemia, basic requirements and new trends. Hemoglobin , 33 Suppl 1 S28 - S36. 10.3109/03630260903346593.

Porter, JB; (2009) Deferasirox: an update. Hemoglobin , 33 Suppl 1 S70 - S75. 10.3109/03630260903347146.

Porter, JB; (2009) Iron toxicity: optimizing chelation therapy across transfusion-dependent anaemias Proceedings of a satellite symposium at the 14th Congress of the European Hematology Association (EHA), held in June 2009 in Berlin Introduction. BLOOD REV , 23 S1 - S1.

Porter, JB; (2009) Optimizing iron chelation strategies in beta-thalassaemia major. BLOOD REVIEWS , 23 S3 - S7.

Porter, JB; (2009) Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease. Hemoglobin , 33 Suppl 1 S37 - S45. 10.3109/03630260903346627.

Porter, JB; Athanasiou-Metaxa, M; Bowden, DK; Troncy, J; Habr, D; Domokos, G; ... Cappellini, MD; + view all (2009) Improved Patient Satisfaction, Adherence and Health-Related Quality of Life with Deferasirox (Exjade (R)) in beta-Thalassemia Patients Previously Receiving Other Iron Chelation Therapies. In: BLOOD. (pp. 980 - 981). AMER SOC HEMATOLOGY

Porter, JB; Piga, A; Cohen, A; Ford, JM; Bodner, J; Cappellini, MD; (2009) ASSESSMENT OF SAFETY IN PATIENTS RECEIVING LONGER-TERM IRON CHELATION THERAPY WITH DEFERASIROX WHO HAD ACHIEVED SERUM FERRITIN LEVELS OF < 1000 NG/ML DURING THE STUDY COURSE. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 77 - 77). FERRATA STORTI FOUNDATION Gold open access

Porter, JB; Yoon, SS; Shen, ZX; Thein, SL; Lin, KH; Habr, D; ... Lee, JW; + view all (2009) IRON CHELATION THERAPY WITH DEFERASIROX FOR TRANSFUSIONAL IRON-OVERLOADED PATIENTS WITH APLASTIC ANAEMIA AND OTHER RARE ANAEMIAS. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 80 - 80). FERRATA STORTI FOUNDATION Gold open access

Postel-Vinay, S; Arkenau, HT; Olmos, D; Ang, J; Barriuso, J; Ashley, S; ... Kaye, S; + view all (2009) Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter? In: Br J Cancer. (pp. 1373 - 1378).

Powis, SJ; Nesbeth, D; Lenart, I; Fussell, H; Lamb, T; Gould, K; Antoniou, AN; (2009) Rapid acidification and alkylation: Redox analysis of the MHC class I pathway. J IMMUNOL METHODS , 340 (1) 81 - 85. 10.1016/j.jim.2008.09.006.

Powis, SJ; Santos, SG; Antoniou, AN; (2009) Biochemical Features of HLA-B27 and Antigen Processing. ADV EXP MED BIOL , 649 210 - 216.

Q

Quinn, AE; Pinkney, M; Piggott, NH; Calvert, H; Milton, ID; Lunec, J; (2009) A Monoclonal Antibody for Detection of Folylpolyglutamate Synthetase in Paraffin Embedded Tissues. HYBRIDOMA , 28 (6) 415 - 421. 10.1089/hyb.2009.0040.

R

Rahim, AA; Wong, AM; Buckley, SM; Hughes, DA; Karlsson, S; Cooper, JD; ... Waddington, SN; + view all (2009) Fetal Gene Therapy for Acute Neuronopathic Gaucher Disease. In: MOLECULAR THERAPY. (pp. S357 - S357). NATURE PUBLISHING GROUP

Rahman, KM; Reszka, AP; Gunaratnam, M; Haider, SM; Howard, PW; Fox, KR; ... Thurston, DE; + view all (2009) Biaryl polyamides as a new class of DNA quadruplex-binding ligands. Chem Commun (Camb) (27) 4097 - 4099. 10.1039/b902359c.

Rees, J; Short, S; Townsley, E; Zadeh, G; Brandner, S; Howard, R; ... Thomas, D; + view all (2009) Neuro-Oncology. In: UNSPECIFIED (771 - 822).

Regad, T; Bellodi, C; Nicotera, P; Salomoni, P; (2009) The tumor suppressor Pml regulates cell fate in the developing neocortex. NAT NEUROSCI , 12 (2) 132 - 140. 10.1038/nn.2251.

Reiss, U; Davidoff, A; Gray, J; Nienhuis, A; Nathwani, A; (2009) Dose response results of self complementary adeno-associated virus (AAV) vector-mediated factor IX gene transfer in non-human primates. HAEMOPHILIA , 15 (2) 635 - 635.

Richardson, SE; Edwards, K; (2009) Accidental acute clidinium toxicity. Emerg Med J , 26 (6) 460 - ?. 10.1136/emj.2008.067926.

Rival, T; Page, RM; Chandraratna, DS; Sendall, TJ; Ryder, E; Liu, B; ... Lomas, DA; + view all (2009) Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease. Eur J Neurosci , 29 (7) 1335 - 1347. 10.1111/j.1460-9568.2009.06701.x.

Robinson, J; Waller, MJ; Fail, SC; McWilliam, H; Lopez, R; Parham, P; Marsh, SGE; (2009) The IMGT/HLA database. D1013 - D1017.

Rocha, R; Vassallo, J; Soares, F; Miller, K; Gobbi, H; (2009) Digital slides: Present status of a tool for consultation, teaching, and quality control in pathology. PATHOL RES PRACT , 205 (11) 735 - 741. 10.1016/j.prp.2009.05.004.

Rocha, RM; Miller, K; Soares, F; Schenka, N; Vassallo, J; Gobbi, H; (2009) Biotin-free systems provide stronger immunohistochemical signal in oestrogen receptor evaluation of breast cancer. J CLIN PATHOL , 62 (8) 699 - 704. 10.1136/jcp.2009.065326.

Roddie, C; Peggs, K; (2009) Hodgkin’s Lymphoma. Medicine , 37 (4) 208 - 211.

Roider, HG; Lenhard, B; Kanhere, A; Haas, SA; Vingron, M; (2009) CpG-depleted promoters harbor tissue-specific transcription factor binding signals-implications for motif overrepresentation analyses. NUCLEIC ACIDS RES , 37 (19) 6305 - 6315. 10.1093/nar/gkp682. Gold open access

Ross, J; Bottardi, S; Bourgoin, V; Wollenschlaeger, A; Drobetsky, E; Trudel, M; Milot, E; (2009) Differential requirement of a distal regulatory region for pre-initiation complex formation at globin gene promoters. NUCLEIC ACIDS RES , 37 (16) 5295 - 5308. 10.1093/nar/gkp545. Gold open access

Rossi, M; Munarriz, ER; Bartesaghi, S; Milanese, M; Dinsdale, D; Guerra-Martin, MA; ... Melino, G; + view all (2009) Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux. J CELL SCI , 122 (18) 3330 - 3339. 10.1242/jcs.048181.

S

Salma, Y; Lafont, E; Therville, N; Carpentier, S; Bonnafé, MJ; Levade, T; ... Andrieu-Abadie, N; + view all (2009) The natural marine anhydrophytosphingosine, Jaspine B, induces apoptosis in melanoma cells by interfering with ceramide metabolism. Biochem Pharmacol , 78 (5) 477 - 485. 10.1016/j.bcp.2009.05.002.

Salomoni, P; (2009) Stemming out of a new PML era? CELL DEATH DIFFER , 16 (8) 1083 - 1092. 10.1038/cdd.2009.63.

Salomoni, P; Calabretta, B; (2009) Targeted therapies and autophagy New insights from chronic myeloid leukemia. AUTOPHAGY , 5 (7) 1050 - 1051.

Salomoni, P; Michod, D; (2009) End of the Daxx diatribe? CELL CYCLE , 8 (10) 1467 - 1468.

Sampath, D; Calin, GA; Puduvalli, VK; Gopisetty, G; Taccioli, C; Liu, CG; ... Plunkett, W; + view all (2009) Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. BLOOD , 113 (16) 3744 - 3753. 10.1182/blood-2008-09-178707.

Sandhu, J; Kaur, B; Armstrong, C; Talbot, CJ; Steward, WP; Farmer, PB; Singh, R; (2009) Determination of 5-methyl-2'-deoxycytidine in genomic DNA using high performance liquid chromatography-ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci , 877 (20-21) 1957 - 1961. 10.1016/j.jchromb.2009.05.032.

Saudemont, A; Garcon, F; Yadi, H; Roche-Molina, M; Kim, N; Segonds-Pichon, A; ... Colucci, F; + view all (2009) p110  and p110  isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease. Proceedings of the National Academy of Sciences , 106 (14) 5795 - 5800. 10.1073/pnas.0808594106.

Schmid, M; Cappellini, MD; Porter, JB; Greenberg, PL; Lawniczek, T; Glaser, S; ... Gattermann, N; + view all (2009) Safety of Deferasirox (Exjade (R)) in Myelodysplastic Syndromes (MDS) and Non-MDS Patients with Transfusional Iron Overload: A Pooled Analysis Focusing On Renal Function. In: BLOOD. (pp. 702 - 703). AMER SOC HEMATOLOGY

Schuh, AH; Knight, SJL; SadighiAkha, E; Enver, T; Taylor, J; (2009) IDENTIFICATION OF NOVEL RECURRENT COPY NUMBER VARIATIONS BY HIGH RESOLUTION COMPARATIVE GENOME HYBRIDISATION. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 136 - 136). FERRATA STORTI FOUNDATION Gold open access

Seymour, LW; Ferry, DR; Kerr, DJ; Rea, D; Whitlock, M; Poyner, R; ... Cassidy, J; + view all (2009) Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. INT J ONCOL , 34 (6) 1629 - 1636. 10.3892/ijo_00000293.

Shalaby, AAE; Presneau, N; Idowu, BD; Thompson, L; Briggs, TRW; Tirabosco, R; ... Flanagan, AM; + view all (2009) Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas. MODERN PATHOL , 22 (8) 996 - 1005. 10.1038/modpathol.2009.63.

Shaw, BE; Apperley, J; Russell, NH; Craddock, CF; Liakopoulou, E; Potter, MN; ... Byrne, JL; + view all (2009) A Comparison of Stem Cell Source in Adult and Paediatric Recipients of T-Cell Depleted Myeloablative Transplants for Standard Risk Leukaemia: No Difference in Mortality Using BM or PBSC. In: BLOOD. (pp. 495 - 496). AMER SOC HEMATOLOGY

Shaw, BE; Fleischhauer, K; Zino, E; Malkki, M; Spellman, S; Morishima, Y; ... Int Histocompatibility Working Grp,; + view all (2009) Significant differences in outcome following unrelated donor HCT can be better predicted using an algorithm incorporating both allele and epitope level matching for HLA-DPB1. In: BONE MARROW TRANSPLANTATION. (pp. S78 - S78). NATURE PUBLISHING GROUP

Shaw, BE; Veys, P; Pagliuca, A; Addada, J; Cook, G; Craddock, CF; ... Hough, RE; + view all (2009) Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms. BONE MARROW TRANSPL , 44 (1) 7 - 12. 10.1038/bmt.2008.420.

Shi, Y; Zhu, J; Salomoni, P; Tucci, P; Lu, X; (2009) A Sino-British frontier workshop of cancer biology. CELL DEATH DIFFER , 16 (4) 648 - 650. 10.1038/cdd.2008.192.

Shih, CS; Laurie, N; Holzmacher, J; Spence, Y; Nathwani, AC; Davidoff, AM; Dyer, MA; (2009) AAV-mediated Local Delivery of Interferon-beta for the Treatment of Retinoblastoma in Preclinical Models. NEUROMOL MED , 11 (1) 43 - 52. 10.1007/s12017-009-8059-0.

Singh, KJDAL; O'Hare, MJ; Pizzey, A; Appasammy, M; Stein, RC; Muttukrishna, S; (2009) Ovarian Granulosa Cells Have Varying Sensitivity to Different Cytotoxic Drugs Used To Treat Young Breast Cancer Patients. REPRODUCTIVE SCIENCES , 16 (3) 151A - 151A.

Slyker, JA; Lohman-Payne, BL; John-Stewart, GC; Maleche-Obimbo, E; Emery, S; Richardson, B; ... Rowland-Jones, SL; + view all (2009) Acute cytomegalovirus infection in Kenyan HIV-infected infants. AIDS , 23 (16) 2173 - 2181. 10.1097/QAD.0b013e32833016e8.

Slyker, JA; Lohman-Payne, BL; Rowland-Jones, SL; Otieno, P; Maleche-Obimbo, E; Richardson, B; ... John-Stewart, GC; + view all (2009) The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants. AIDS , 23 (1) 117 - 124. 10.1097/QAD.0b013e32831c8abd.

Smith, BN; Ancliff, PJ; Pizzey, A; Khwaja, A; Linch, DC; Gale, RE; (2009) Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds. BRIT J HAEMATOL , 144 (5) 762 - 770. 10.1111/j.1365-2141.2008.07493.x.

Sobota, A; Yamashita, R; Xu, Y; Trachtenberg, F; Kleinert, DA; Giardina, PJ; ... Neufeld, EJ; + view all (2009) Quality of Life in Adolescents and Adults with Thalassemia: A Report of the Thalassemia Longitudinal Cohort. In: BLOOD. (pp. 232 - 232). AMER SOC HEMATOLOGY

Sorio, C; Martinelli, GV; Monne, M; Vezzalini, M; Moratti, E; Mafficini, A; Della Peruta, M; (2009) DOWN-REGULATION OF PROTEIN TYROSINE PHOSPHATASE GAMMA (PTPRG) IN CHRONIC MYELOID LEUKEMIA (CML). In: ANNALS OF ONCOLOGY. (pp. 39 - 39). OXFORD UNIV PRESS

Spencer, J; Rathnam, RP; Motukuri, M; Kotha, AK; Richardson, SCW; Hazrati, A; ... Hursthouse, MB; + view all (2009) Synthesis of a 1,4-benzodiazepine containing palladacycle with in vitro anticancer and cathepsin B activity. DALTON T (22) 4299 - 4303. 10.1039/b819061e.

Srirajaskanthan, R; Dancey, G; Hackshaw, A; Luong, T; Caplin, ME; Meyer, T; (2009) Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosis. ENDOCR-RELAT CANCER , 16 (3) 967 - 976. 10.1677/ERC-09-0089.

Srirajaskanthan, R; Desai, K; Jayaratnam, A; Carras, E; Toumpanakis, C; Meyer, T; Caplin, M; (2009) Uncommon sites for metastasis of neuroendocrine tumor in adults. In: JOURNAL OF CLINICAL ONCOLOGY.

Srirajaskanthan, R; McStay, M; Toumpanakis, C; Meyer, T; Caplin, ME; (2009) Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review. Neuroendocrinology , 89 (1) 48 - 55. 10.1159/000151222.

Srirajaskanthan, R; Toumpanakis, C; Karpathakis, A; Marelli, L; Quigley, AM; Dusmet, M; ... Caplin, ME; + view all (2009) Surgical management and palliative treatment in bronchial neuroendocrine tumours: a clinical study of 45 patients. Lung Cancer , 65 (1) 68 - 73. 10.1016/j.lungcan.2008.10.025.

Srirajaskanthan, R; Toumpanakis, C; Meyer, T; Caplin, ME; (2009) Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours. Aliment Pharmacol Ther , 29 (11) 1143 - 1154. 10.1111/j.1365-2036.2009.03988.x.

Stavroulis, AI; Saridogan, E; Benjamin, E; Cutner, AS; (2009) Can high histological confirmation rates be achieved for pelvic endometriosis? J OBSTET GYNAECOL , 29 (8) 729 - 731. 10.3109/01443610903165537.

Steele, AJ; Prentice, AG; Cwynarski, K; Hoffbrand, AV; Wickremasinghe, RG; (2009) 2-phenylacetylenesulphonamide induces p53-independent apoptosis of CLL cells via upregulation of the BH3 protein Noxa. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 1 - 1). WILEY-BLACKWELL PUBLISHING, INC

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; ... Wickremasinghe, RG; + view all (2009) 2-phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. BLOOD , 114 (6) 1217 - 1225. 10.1182/blood-2008-11-190587.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; ... Wickremasinghe, RG; + view all (2009) 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. Blood , 114 (6) 1217 - 1225. 10.1182/blood-2008-11-190587.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; ... Wickremasinghe, RG; + view all (2009) 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. Blood , 114 (6) 1217 - 1225. 10.1182/blood-2008-11-190587.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; North, JM; Nacheva, EP; ... Wickremasinghe, RG; + view all (2009) 2-phenylacetylenesulfonamise(PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia cells (CLL) cells. Blood , 114 (6) 1217 - 1225.

Stephens, HA; Cox, S; Fernando, R; Howie, AJ; Harber, M; Little, A-M; (2009) MICA ANTIBODIES ASSOCIATE WITH BIOPSY-PROVEN CELLULAR REJECTION IN RENAL TRANSPLANT RECIPIENTS. TRANSPLANT INTERNATIONAL , 22 69 - 69.

Stieger, K; Lhériteau, E; Moullier, P; Rolling, F; (2009) AAV-mediated gene therapy for retinal disorders in large animal models. ILAR J , 50 (2) 206 - 224.

Sun, Y; Kong, W; Falk, A; Hu, J; Zhou, L; Pollard, S; Smith, A; (2009) CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent. PLoS One , 4 (5) , Article e5498 . 10.1371/journal.pone.0005498. Green open access
file

Swanton, C; Nicke, B; Schuett, M; Eklund, AC; Ng, C; Li, Q; ... Downward, J; + view all (2009) Chromosomal instability determines taxane response. Proc Natl Acad Sci U S A , 106 (21) 8671 - 8676. 10.1073/pnas.0811835106.

T

Taccioli, C; Fabbri, E; Visone, R; Volinia, S; Calin, GA; Fong, LY; ... Croce, CM; + view all (2009) UCbase & miRfunc: a database of ultraconserved sequences and microRNA function. NUCLEIC ACIDS RES , 37 D41 - D48. 10.1093/nar/gkn702. Gold open access

Taccioli, C; Wan, SG; Liu, CG; Alder, H; Volinia, S; Farber, JL; ... Fong, LYY; + view all (2009) Zinc Replenishment Reverses Overexpression of the Proinflammatory Mediator S100A8 and Esophageal Preneoplasia in the Rat. GASTROENTEROLOGY , 136 (3) 953 - 966. 10.1053/j.gastro.2008.11.039.

Taher, A; Cappellini, MD; Vichinsky, E; Galanello, R; Piga, A; Lawniczek, T; ... Porter, JB; + view all (2009) Efficacy and safety of deferasirox doses of > 30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload. BRIT J HAEMATOL , 147 (5) 752 - 759. 10.1111/j.1365-2141.2009.07908.x.

Taher, A; Koren, A; Tamary, H; Cappellini, MD; Porter, JB; Habr, D; ... Viprakasit, V; + view all (2009) EFFICACY AND SAFETY OF DEFERASIROX IN CHELATION-NAIVE PATIENTS WITH B-THALASSAEMIA MAJOR: RESULTS FROM THE LARGE-SCALE EPIC STUDY. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 313 - 314). FERRATA STORTI FOUNDATION Gold open access

Takehara, S; Onda, M; Zhang, J; Nishiyama, M; Yang, X; Mikami, B; Lomas, DA; (2009) The 2.1-A crystal structure of native neuroserpin reveals unique structural elements that contribute to conformational instability. J Mol Biol , 388 (1) 11 - 20. 10.1016/j.jmb.2009.03.007.

Tan, DS; Brunetto, AT; Ang, J; Olmos, D; Barriuso, J; Frentzas, S; ... Kaye, SB; + view all (2009) Unplanned hospital admissions as an early surrogate indicator of patient (pt) attrition in phase I trials. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Tan, MH; Smith, AJ; Pawlyk, B; Xu, XY; Liu, XQ; Bainbridge, JB; ... Ali, RR; + view all (2009) Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors. Human Molecular Genetics , 18 (12) 2099 - 2114. 10.1093/hmg/ddp133. Green open access
file

Thephinlap, C; Phisalaphong, C; Fucharoen, S; Porter, JB; Srichairatanakool, S; (2009) Efficacy of Curcuminoids in Alleviation of Iron Overload and Lipid Peroxidation in Thalassemic Mice. MED CHEM , 5 (5) 474 - 482.

Thind, A; Freeman, T; Thorpe, C; Burt, A; Stewart, M; (2009) Family physicians' satisfaction with current practice: what is the role of their interactions with specialists? Healthc Policy , 4 (3) e145 - e158.

Thoma, CR; Toso, A; Gutbrodt, KL; Reggi, SP; Frew, IJ; Schraml, P; ... Krek, W; + view all (2009) VHL loss causes spindle misorientation and chromosome instability. NAT CELL BIOL , 11 (8) 994 - U200. 10.1038/ncb1912.

Tipping, AJ; Pina, C; Castor, A; Hong, DL; Rodrigues, NP; Lazzari, L; ... Enver, T; + view all (2009) High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle. BLOOD , 113 (12) 2661 - 2672. 10.1182/blood-2008-06-161117.

Tirabosco, R; Hing, S; Carlstedt, T; Flanagan, AM; (2009) Intraneural Perineurioma. FISH Assessment of the BCR Locus in 7 Cases. In: LABORATORY INVESTIGATION. (pp. 24A - 24A). NATURE PUBLISHING GROUP

Tirabosco, R; Hing, S; Carlstedx, T; Flanagan, AM; (2009) Intraneural Perineurioma. FISH Assessment of the BCR Locus in 7 Cases. In: MODERN PATHOLOGY. (pp. 24A - 24A). NATURE PUBLISHING GROUP

Tirabosco, R; Lang-Lazdunski, L; Diss, TC; Amary, MFC; Rodriguez-Justo, M; Landau, D; ... Flanagan, AM; + view all (2009) Clear cell sarcoma of the mediastinum. ANN DIAGN PATHOL , 13 (3) 197 - 200. 10.1016/j.anndiagpath.2008.02.014.

Toumpanakis, C; Quigley, A; Srirajaskanthan, R; Marelli, L; Singhrao, T; Meyer, T; ... Caplin, ME; + view all (2009) 90-Yttrium-DOTA-octreotate for the treatment of advanced neuroendocrine tumors. In: JOURNAL OF CLINICAL ONCOLOGY.

Townsend, W; Cross, NCP; Waghorn, K; Somana, K; Ramsay, A; Thomson, K; Peggs, K; (2009) Clinical evidence for a graft-versus-tumour effect following allogeneic HSCT for t(8;13) atypical myeloproliferative disorder. BONE MARROW TRANSPL , 44 (3) 197 - 199. 10.1038/bmt.2008.448.

Tsao, EH; Kellam, P; Sin, CSY; Rasaiyaah, J; Griffiths, PD; Clark, DA; (2009) Microarray-based determination of the lytic cascade of human herpesvirus 6B. J GEN VIROL , 90 2581 - 2591. 10.1099/vir.0.012815-0.

Tulpule, S; Shaw, BE; Makoni, P; Little, AM; Madrigal, JA; Goldman, JM; (2009) Severe allergic reaction with anaphylaxis to G-CSF (lenograstim) in a healthy donor. BONE MARROW TRANSPL , 44 (2) 129 - 130. 10.1038/bmt.2008.438.

V

Valle, JW; Wasan, H; Johnson, P; Jones, E; Dixon, L; Swindell, R; ... Bridgewater, J; + view all (2009) Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. BRIT J CANCER , 101 (4) 621 - 627. 10.1038/sj.bjc.6605211.

Van Cutsem, E; Rivera, F; Berry, S; Kretzschmar, A; Michael, M; DiBartolomeo, M; ... First BEAT investigators,; + view all (2009) Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol , 20 (11) 1842 - 1847. 10.1093/annonc/mdp233.

Varughese, MA; Ledermann, JA; (2009) Trial design strategies for vascular-targeted therapy of patients with ovarian cancer. Clinical Ovarian Cancer , 2 (1) 24 - 30. 10.3816/COC.2009.n.003.

Vassileva, V; (2009) Aberrant methylation - Early biomarker for CRC. Nature Reviews Clinical Oncology , 6 (12) 676 - 676. 10.1038/nrclinonc.2009.176.

Vassileva, V; (2009) Chemotherapy: Metastatic breast cancer—optimal front-line therapy. Nature Reviews Clinical Oncology , 6 (10) 557 - 557. 10.1038/nrclinonc.2009.135.

Vassileva, V; (2009) Chemotherapy: Predictors of chemotherapy response in advanced CRC. Nature Reviews Clinical Oncology , 6 (5) 245 - 245. 10.1038/nrclinonc.2009.31.

Vassileva, V; (2009) Diagnostic markers for ovarian cancer. Nature Reviews Clinical Oncology , 6 (12) 678 - 678. 10.1038/nrclinonc.2009.175.

Vassileva, V; (2009) Hematology: Early markers for leukemia. Nature Reviews Clinical Oncology , 6 (5) 245 - 245. 10.1038/nrclinonc.2009.34.

Vassileva, V; (2009) Imaging: FDG-PET/CT: early predictor of treatment response in soft-tissue sarcoma. Nature Reviews Clinical Oncology , 6 (7) 376 - 376. 10.1038/nrclinonc.2009.76.

Vassileva, V; (2009) Immunotherapy: Recurrence-free survival versus quality of life—where do we draw the line? Nature Reviews Clinical Oncology , 6 (9) 498 - 498. 10.1038/nrclinonc.2009.117.

Vassileva, V; (2009) Improved survival for SCRLM. Nature Reviews Clinical Oncology , 6 (9) 496 - 496. 10.1038/nrclinonc.2009.124.

Vassileva, V; (2009) MRI and molecular profiles: Improving prediction. Nature Reviews Clinical Oncology , 6 (8) 435 - 435. 10.1038/nrclinonc.2009.95.

Vassileva, V; (2009) Overdiagnosis with mammography? Nature Reviews Clinical Oncology , 6 (10) 556 - 556. 10.1038/nrclinonc.2009.138.

Vassileva, V; (2009) Pathology: Prostate cancer—personalized response prediction. Nature Reviews Clinical Oncology , 6 (11) 618 - 618. 10.1038/nrclinonc.2009.156.

Vassileva, V; (2009) Pathology: Protein kinase A predicts response to radiation and androgen deprivation therapy. Nature Reviews Clinical Oncology , 6 (11) 615 - 615. 10.1038/nrclinonc.2009.154.

Vassileva, V; (2009) Pediatric oncology: Aggressive treatment of osteosarcoma improves health-related quality of life. Nature Reviews Clinical Oncology , 6 (9) 498 - 498. 10.1038/nrclinonc.2009.123.

Vassileva, V; (2009) Prostate cancer: check it out. Nature Reviews Clinical Oncology , 6 (6) 303 - 303. 10.1038/nrclinonc.2009.53.

Vassileva, V; (2009) Surgery: Rectal cancer—treatment on the less invasive side. Nature Reviews Clinical Oncology , 6 (10) 557 - 557. 10.1038/nrclinonc.2009.136.

Vassileva, V; (2009) Surgical oncology: Markers of long-term survival in pancreatic cancer. Nature Reviews Clinical Oncology , 6 (7) 375 - 375. 10.1038/nrclinonc.2009.74.

Vassileva, V; (2009) Survivin: Surviving gastric cancer. Nature Reviews Clinical Oncology , 6 (8) 436 - 436. 10.1038/nrclinonc.2009.96.

Vassileva, V; (2009) Targeted therapies: Bevacizumab and chemotherapy in NSCLC. Nature Reviews Clinical Oncology , 6 (6) 304 - 304. 10.1038/nrclinonc.2009.54.

UNSPECIFIED (Ed). (2009) High dose equals improved response. [Whole issue]. Nature Reviews Clinical Oncology , 6 (12).

Veeriah, S; Brennan, C; Meng, S; Singh, B; Fagin, JA; Solit, DB; ... Chan, TA; + view all (2009) The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc Natl Acad Sci U S A , 106 (23) 9435 - 9440. 10.1073/pnas.0900571106.

Velica, P; Davies, NJ; Rocha, PP; Schrewe, H; Ride, JP; Bunce, CM; (2009) Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers. MOL CANCER , 8 , Article 121. 10.1186/1476-4598-8-121. Gold open access

Vergara, C; Caraballo, L; Mercado, D; Jimenez, S; Rojas, W; Rafaels, N; ... Barnes, KC; + view all (2009) African ancestry is associated with risk of asthma and high total serum IgE in a population from the Caribbean Coast of Colombia. HUM GENET , 125 (5-6) 565 - 579. 10.1007/s00439-009-0649-2.

Vergote, I; Calvert, H; Kania, M; Kaiser, C; Zimmermann, AH; Sehouli, J; (2009) A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer. EUR J CANCER , 45 (8) 1415 - 1423. 10.1016/j.ejca.2008.12.013.

Villegas, SN; Oikonomoulu, I; Morrison, G; Soneji, S; Enver, T; Brickman, J; (2009) Identification of genes expressed in the anterior definitive endoderm. In: MECHANISMS OF DEVELOPMENT. (pp. S239 - S240). ELSEVIER SCIENCE BV

Virgili, A; Brazma, D; Grace, C; Nacheva, EP; (2009) Deletions of the Normal ABL1 at the Non-Translocated Chromosome 9 in CML Associated with TKI Resistance. In: BLOOD. (pp. 1260 - 1260). AMER SOC HEMATOLOGY

Visone, R; Rassenti, LZ; Veronese, A; Taccioli, C; Costinean, S; Aguda, BD; ... Croce, CM; + view all (2009) Karyotype-specific microRNA signature in chronic lymphocytic leukemia. BLOOD , 114 (18) 3872 - 3879. 10.1182/blood-2009-06-229211.

Vontell, R; McGuinness, L; Goldring, K; David, D; John, S; (2009) Antigen retrieval improves the immunoreactivity of cells and receptor sites of the basal ganglia on rat and human brains. In: MOVEMENT DISORDERS. (pp. S218 - S218). WILEY-LISS

W

Wang, D; Zhang, S; He, F; Zhu, J; Hu, S; Yu, J; (2009) How do variable substitution rates influence Ka and Ks calculations? Genomics Proteomics Bioinformatics , 7 (3) 116 - 127. 10.1016/S1672-0229(08)60040-6.

Wang, D-P; Wan, H-L; Zhang, S; Yu, J; (2009) γ-MYN: a new algorithm for estimating Ka and Ks with consideration of variable substitution rates. Biology Direct , 4 (1) 20 - 20. 10.1186/1745-6150-4-20. Gold open access

Ward, NJ; Apolonia, L; Cochrane, M; Buckley, SM; Waddington, SN; Nathwani, AC; ... Thrasher, AJ; + view all (2009) Nonintegrating Lentiviral Vectors for Treatment of Haemophilia B. In: MOLECULAR THERAPY. (pp. S310 - S310). NATURE PUBLISHING GROUP

Werbowetski-Ogilvie, TE; Bossé, M; Stewart, M; Schnerch, A; Ramos-Mejia, V; Rouleau, A; ... Bhatia, M; + view all (2009) Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol , 27 (1) 91 - 97. 10.1038/nbt.1516.

West, M; Nicholls, K; Mehta, A; Clarke, JT; Steiner, R; Beck, M; ... Schiffman, R; + view all (2009) Agalsidase alfa and kidney dysfunction in Fabry disease. Journal of the American Society of Nephrology , 20 (5) 1132 - 1139.

Westbury, CB; Reis-Filho, JS; Dexter, T; Mahler-Araujo, B; Fenwick, K; Iravani, M; ... Isacke, CM; + view all (2009) Genome-wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c-Kit, CD117) and oestrogen receptor-alpha (ER alpha) in response to therapeutic radiation. J PATHOL , 219 (1) 131 - 140. 10.1002/path.2581.

Westrate, L; Mackay, H; Brown, T; Nguyen, B; Kluza, J; Wilson, WD; ... Hartley, JA; + view all (2009) Effects of the N-Terminal Acylamido Group of Imidazole- and Pyrrole-Containing Polyamides on DNA Sequence Specificity and Binding Affinity. BIOCHEMISTRY-US , 48 (24) 5679 - 5688. 10.1021/bi900242t.

Wetterskog, D; Moshiri, A; Ozaki, T; Uramoto, H; Nakagawara, A; Funa, K; (2009) Dysregulation of platelet-derived growth factor beta-receptor expression by DeltaNp73 in neuroblastoma. Mol Cancer Res , 7 (12) 2031 - 2039. 10.1158/1541-7786.MCR-08-0501.

Whelan, J; (2009) Managing sarcomas in teenagers and young adults. In: EJC SUPPLEMENTS. (pp. 82 - 82). PERGAMON-ELSEVIER SCIENCE LTD

Whelan, JS; Patterson, D; Perisoglou, M; Bielack, S; Marina, N; Smeland, S; Bernstein, M; (2009) The role of interferons in the treatment of osteosarcoma. Pediatric Blood and Cancer 10.1002/pbc.22136.

Wiegant, FA; Surinova, S; Ytsma, E; Langelaar-Makkinje, M; Wikman, G; Post, JA; (2009) Plant adaptogens increase lifespan and stress resistance in C. elegans. Biogerontology , 10 (1) 27 - 42. 10.1007/s10522-008-9151-9.

Windsor, R; Strauss, S; Seddon, B; Michelagnoli, M; Labrum, R; Wood, N; ... J,; + view all (2009) A pilot pharmacogenomic study of the influence of cytotoxic target and metabolising gene polymorphisms on toxicity and response in osteosarcoma. In: European Musculoskeletal Oncology Society, Stuttgart, May 2009.

Windsor, R; Strauss, S; Seddon, B; Whelan, J; (2009) Experimental therapies in Ewing's sarcoma. EXPERT OPIN INV DRUG , 18 (2) 143 - 159. 10.1517/13543780802715784.

Wood-Kaczmar, A; Gandhi, S; Yao, Z; Abramov, AY; Miljan, EA; Keen, G; ... Wood, NW; + view all (2009) PINK1 is necessary for long term survival and mitochondrial function in primary human dopaminergic neurons. In: JOURNAL OF NEUROCHEMISTRY. (pp. 301 - 302). WILEY-BLACKWELL PUBLISHING, INC

Wright, TG; Singh, VK; Li, JJ; Foley, JH; Miller, F; Jia, Z; Elliott, BE; (2009) Increased production and secretion of HGF α-chain and an antagonistic HGF fragment in a human breast cancer progression model. International Journal of Cancer , 125 (5) 1004 - 1015. 10.1002/ijc.24364.

Wu, P; Davies, FE; Boyd, K; Thomas, K; Dines, S; Saso, RM; ... Morgan, GJ; + view all (2009) The impact of extramedullary disease at presentation on the outcome of myeloma. LEUKEMIA LYMPHOMA , 50 (2) 230 - 235. 10.1080/10428190802657751.

Y

Ydreborg, M; Dhillon, AP; Burroughs, AK; Lagging, M; Manousou, P; Westin, J; (2009) LIVER HISTOLOGY ONE YEAR POST-TRANSPLANT PREDICTS PROGRESSION OF FIBROSIS AND DEFINES SEVERE HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION. In: HEPATOLOGY. (pp. 546A - 546A). JOHN WILEY & SONS INC

Yovine, A; Casali, P; G, RF; Vermorken, J; Demetri, G; Whelan, JS; ... Schoffski, P; + view all (2009) Trabectidin 3 hour infusion every 3 weeks in pre-treated advanced sarcoma patients: acompassionate use administration experience. In: European Journal of Cancer. (pp. 597 - ?).

Z

Zhang, EZ; Laufer, JG; Pedley, RB; Beard, PC; (2009) In vivo high-resolution 3D photoacoustic imaging of superficial vascular anatomy. PHYS MED BIOL , 54 (4) 1035 - 1046. 10.1088/0031-9155/54/4/014.

Zhu, G; Agusti, A; Gulsvik, A; Bakke, P; Coxson, H; Lomas, DA; ... ICGN investigators,; + view all (2009) CTLA4 gene polymorphisms are associated with chronic bronchitis. Eur Respir J , 34 (3) 598 - 604. 10.1183/09031936.00141808.

Zhu, G; ICGN Investigators,; Gulsvik, A; Bakke, P; Ghatta, S; Anderson, W; ... Pillai, SG; + view all (2009) Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease. Hum Mol Genet , 18 (11) 2053 - 2062. 10.1093/hmg/ddp111.

This list was generated on Sun Apr 19 10:23:36 2015 BST.